AGREEMENT AND PLAN OF MERGER BY AND AMONG GOFISH CORPORATION, BM ACQUISITION CORP, INC., BOLT, INC. AND THE INDEMNIFICATION REPRESENTATIVE February 11, 2007
AGREEMENT
AND PLAN OF MERGER
BY
AND
AMONG
GOFISH
CORPORATION, BM ACQUISITION CORP, INC.,
BOLT,
INC.
AND
THE
INDEMNIFICATION REPRESENTATIVE
February
11, 2007
AGREEMENT
AND PLAN OF MERGER
Agreement
entered into as of February 11, 2007 by and among GoFish Corporation, a Nevada
corporation (the “Buyer”), BM Acquisition Corp Inc., a Delaware corporation and
a wholly-owned subsidiary of the Buyer (the “Transitory Subsidiary”), Bolt,
Inc., a/k/a Bolt Media, Inc. a Delaware corporation (the “Company”) and Xxxx
Xxxxx (the “Indemnification Representative”). The Buyer, the Transitory
Subsidiary and the Company are referred to collectively herein as the
“Parties.”
This
Agreement contemplates a merger of the Company with and into the Transitory
Subsidiary. In such Merger (as defined below), the stockholders of the Company
will receive Merger Consideration (as defined below) in exchange for their
capital stock of the Company.
Buyer,
Transitory Subsidiary, and the Company desire that the Merger qualifies as
a
“plan of reorganization” under Section 368(a) of the Internal Revenue Code of
1986, as amended (the “Code”).
As
a
condition and further inducement to Buyer to enter into this Agreement and
incur
the obligations set forth herein, Xxxxx Xxxxx, Xxxxx Xxxxx and Xxx Xxxxxx (each,
a “Major Stockholder”) concurrently herewith are entering into a Stockholders
Support Agreement (the “Stockholders Support Agreement”), dated as of the date
hereof with Buyer, in the form attached hereto as Exhibit
A,
pursuant to which each such Major Stockholder has, among other things, upon
the
terms and subject to the conditions set forth therein, agreed (i) to vote
all Company Shares that are beneficially owned by him in favor of the adoption
of this Agreement and the approval of the Merger and (ii) not to vote any
Company Shares in favor of any other acquisition (whether by way of merger,
consolidation, share exchange, stock purchase or asset purchase) of all or
a
majority of the outstanding capital stock or assets of the Company other than
a
Superior Offer (as defined below).
Now,
therefore, in consideration of the representations, warranties and covenants
herein contained, the Parties agree as follows.
ARTICLE
I
THE
MERGER
1.1 The
Merger.
Upon
and subject to the terms and conditions of this Agreement, the Company shall
merge with and into the Transitory Subsidiary (with such merger referred to
herein as the “Merger”) at the Effective Time (as defined below). From and after
the Effective Time, the separate corporate existence of the Company shall cease
and the Transitory Subsidiary shall continue as the surviving corporation in
the
Merger (the “Surviving Corporation”). The “Effective Time” shall be the time at
which the Surviving Corporation files a certificate of merger or other
appropriate documents prepared and executed in accordance with
Section 251(c) of the Delaware General Corporation Law (the “Certificate of
Merger”) with the Secretary of State of the State of Delaware. The Merger shall
have the effects set forth in Section 259 of the Delaware General
Corporation Law.
1.2 The
Closing.
The
closing of the transactions contemplated by this Agreement (the “Closing”) shall
take place at the offices of McGuireWoods LLP in New York, New York, commencing
at 9:00 a.m. local time on March 15, 2007, or, if all of the conditions to
the obligations of the Parties to consummate the transactions contemplated
hereby have not been satisfied or waived by such date, on such mutually
agreeable later date up to the Termination Date as soon as practicable (and
in
any event not later than three business days) after the satisfaction or waiver
of all conditions (excluding the delivery of any documents to be delivered
at
the Closing by any of the Parties) set forth in Article V hereof (the
“Closing Date”).
1.3 Actions
at the Closing.
At the
Closing:
(a) the
Company shall deliver to the Buyer and the Transitory Subsidiary the various
certificates, instruments and documents referred to in
Section 5.2;
(b) the
Buyer
and the Transitory Subsidiary shall deliver to the Company the various
certificates, instruments and documents referred to in
Section 5.3;
(c) the
Surviving Corporation shall file with the Secretary of State of the State of
Delaware the Certificate of Merger;
(d) each
of
the stockholders of record of the Company immediately prior to the Effective
Time (the “Company Stockholders”) shall deliver to the Buyer the certificate(s)
representing his, her or its Company Shares (as defined below);
(e) the
Buyer
shall deliver certificates for the shares of Buyer Common Stock to each former
Company Stockholder in accordance with Section 1.5, and
(f) the
Buyer, the Indemnification Representative and US Bank Trust National Association
(the “Escrow Agent”) shall execute and deliver an
Escrow
Agreement attached hereto as Exhibit B
(the
“Escrow Agreement”) and the Buyer shall deliver to the Escrow Agent (x) a
certificate for the Escrow Shares being placed in escrow on the Closing Date
pursuant to Section 1.9 (collectively, the “Escrow Fund”).
1.4 Additional
Action.
The
Surviving Corporation may, at any time after the Effective Time, take any
action, including executing and delivering any document, in the name and on
behalf of either the Company or the Transitory Subsidiary, in order to
consummate the transactions contemplated by this Agreement.
1.5 Merger
Consideration; Conversion of Shares.
The
aggregate consideration that the Company Stockholders will be entitled to
receive by virtue of the Merger shall be the Buyer Common Stock issuable as
set
forth below (collectively, the “Merger Consideration”).
(a) Conversion
of Shares.
At the
Effective Time, by virtue of the Merger and without any action on the part
of
any Party or the holder of any of the following securities:
(i) Each
share of Preferred Stock, $0.001 par value per share, of the Company (“Preferred
Shares”; and, together with the Common Shares, the “Company Shares”) issued and
outstanding immediately prior to the Effective Time and not converted into
Common Shares at the Effective Time (other than Preferred Shares owned
beneficially by the Buyer or the Transitory Subsidiary, Dissenting Shares,
any
Preferred Shares held in the Company’s treasury and any Preferred Shares issued
in the name of the Escrow Agent pursuant to Section 1.9) shall be converted
into
and represent the right to receive a number of shares of Buyer Common Stock
equal to (x) the liquidation preference per share, including all accrued
dividends thereon, for the applicable class or series to which such Preferred
Share belongs divided by (y) the Average Pre-Signing Price.
2
(ii)
Ten
percent (10%) of the shares of Buyer Common Stock issuable to each former holder
of Preferred Shares shall be subject to the Escrow Agreement pursuant to Section
1.3(f)
(the
“Preferred Escrow Shares”).
(iii) Each
share of common stock, $0.001 par value per share, of the Company (“Common
Shares”) issued and outstanding immediately prior to the Effective Time (after
giving effect to the conversion into Common Shares of all outstanding Preferred
Shares that have converted into Common Shares prior to the Closing and excluding
any Common Shares owned beneficially by the Buyer or the Transitory Subsidiary,
Dissenting Shares, Common Shares held in the Company’s treasury and any Common
Shares issued in the name of the Escrow Agent pursuant to Section 1.9) shall
be
converted into and represent the right to receive (subject to the provisions
of
Section 1.9) such number of shares of common stock, $0.001 par value per
share, of the Buyer (“Buyer Common Stock”) as is equal to the Basic Common
Conversion Ratio (as defined below), (the “Basic Shares”), allocated to the
Company Stockholders who are holders of Common Shares immediately prior to
the
Effective Time (including Common Shares issued upon conversion of Preferred
Shares immediately prior to the Effective Time), allocated as follows: (x)
0% of
the Basic Shares shall be issued to Xxxxx Xxxxx, Xxx Xxxxx and Xxxxx Xxxxxx
and
other employees of the Company named on Schedule 1.5(a)(iii)
(the
“Managing Shareholders”), allocated among them in the percentages set forth on
Schedule 1.5(a)(iii),
and (y)
100% of the Basic Shares shall be issued to the Company Stockholders holding
Common Shares other than the Managing Shareholders (the “Non-Managing
Shareholders”), allocated on a pro rata basis according to the amount of Common
Shares held by each such Non-Managing Shareholder in proportion to the aggregate
amount of Common Shares held by all Non-Managing Shareholders.
The
“Basic Common Conversion Ratio” shall be the result obtained by dividing (i)
$500,000 by (ii) the number of outstanding Common Shares held by
Non-Managing Shareholders immediately prior to the Effective Time (after giving
effect to the exchange into Common Shares of all outstanding Preferred Shares
and Options that have been converted into or exercised for Common Shares prior
to the Closing), and dividing such amount by (iii) the greater of (A) the
average of the last reported sale prices per share of the Buyer Common Stock
on
the NASD OTC Bulletin Board (the “OTCBB”) over the twenty (20) consecutive
trading days ending on the trading day that is two (2) trading days prior to
the
date hereof and (B) if the transactions contemplated by this Agreement are
publicly disclosed by Buyer prior to the date of this Agreement, the average
of
the last reported sale prices per share of the Buyer Common Stock on the OTCBB
over the twenty (20) consecutive
trading days ending on the trading day that is two (2) trading days prior to
such public announcement not to exceed $4.50 per share of Buyer Common Stock,
subject to equitable adjustment in the event of any stock split, stock dividend,
reverse stock split or similar event affecting the Buyer Common Stock between
the beginning of such twenty-day period and the Effective Time (the “Average
Pre-Signing Price”).
3
(iv)
Ten
percent (10%) of the Basic Shares issuable to each former holder of Common
Shares shall be subject to the Escrow Agreement pursuant to Section 1.3(f)
(the
“Basic Escrow Shares”).
(v) In
addition to the Basic Shares issuable pursuant to Section 1.5(a)(iii),
those
Persons holding Common Shares issued and outstanding immediately prior to the
Effective Time (other than Common Shares owned beneficially by the Buyer or
the
Transitory Subsidiary, Dissenting Shares, Common Shares held in the Company’s
treasury and any Common Shares issued in the name of the Escrow Agent pursuant
to Section 1.9) shall receive, subject to the terms, conditions and restrictions
set forth in Schedule 1.5(a)(v),
such
number of Shares of Buyer Common Stock (the “Subsequent Shares”) as follows: (x)
80% of the Subsequent Shares shall be issued to the Managing Shareholders,
allocated as set forth in Schedule 1.5(a)(iii)
and (y)
20% of the Subsequent Shares shall be issued to the Non-Managing Shareholders,
allocated on a pro rata basis according to the amount of Common Shares held
by
each such Non-Managing Shareholder in proportion to the aggregate amount of
Common Shares held by all Non-Managing Shareholders.
The
Basic
Shares and the Subsequent Shares shall together be referred to herein as the
“Merger Shares.”
(vi)
In
addition to being subject to the other restrictions on the Subsequent Shares,
the first in time to be issued of the Subsequent Shares, in an amount equal
to
$1,500,000 divided by the Average Pre-Signing Price, issuable to each former
holder of Common Shares shall be subject to the Escrow Agreement pursuant to
Section 1.3(f)
(the
“Subsequent Escrow Shares” and together with the Preferred Escrow Shares and the
Basic Escrow Shares, the “Escrow Shares”).
(vii) Each
Company Share held in the Company’s treasury immediately prior to the Effective
Time, each Company Share owned beneficially by the Buyer or the Transitory
Subsidiary and any Company Shares issued in the name of the Escrow Agent
pursuant to Section 1.9 shall be cancelled and retired without payment of any
consideration therefor.
(viii) Each
share of common stock, $0.001 par value per share, of the Transitory Subsidiary
issued and outstanding immediately prior to the Effective Time shall be
converted into and thereafter evidence one share of common stock, $0.001 par
value per share, of the Surviving Corporation.
(b) Indebtedness.
All
indebtedness of the Company evidenced by promissory notes outstanding
immediately prior to the Effective Time shall be converted into and represent
the right to receive a number of shares of Buyer Common Stock equal to (x)
the
principal and accrued interest thereon divided by (y) the Average Pre-Signing
Price.
1.6 Dissenting
Shares.
4
(a) For
purposes of this Agreement, “Dissenting Shares” means Company Shares held as of
the Effective Time by a Company Stockholder who has not voted such Company
Shares in favor of the adoption of this Agreement and the Merger and with
respect to which appraisal shall have been duly demanded and perfected in
accordance with Section 262 of the Delaware General Corporation Law and not
effectively withdrawn or forfeited prior to the Effective Time. Dissenting
Shares shall not be converted into or represent the right to receive Merger
Consideration, unless such Company Stockholder shall have forfeited his, her
or
its right to appraisal under the Delaware General Corporation Law or properly
withdrawn, his, her or its demand for appraisal. If such Company Stockholder
has
so forfeited or withdrawn his, her or its right to appraisal of Dissenting
Shares, then (i) as of the occurrence of such event, such holder’s
Dissenting Shares shall cease to be Dissenting Shares and shall be converted
into and represent the right to receive the Merger Consideration issuable in
respect of such Company Shares pursuant to Section 1.5, and (ii) and
shall be exchangeable solely for the right to receive the applicable Merger
Consideration.
(b) The
Company shall give the Buyer (i) prompt notice of any written demands for
appraisal of any Company Shares, withdrawals of such demands, and any other
instruments that relate to such demands received by the Company and
(ii) the opportunity to direct all negotiations and proceedings with
respect to demands for appraisal under the Delaware General Corporation Law.
The
Company shall not, except with the prior written consent of the Buyer, make
any
payment with respect to any demands for appraisal of Company Shares or offer
to
settle or settle any such demands.
1.7 Fractional
Shares.
No
certificates or scrip representing fractional Merger Shares shall be issued
to
former Company Stockholders upon the surrender for exchange of Company Shares
or
certificates that, immediately prior to the Effective Time, represented Company
Shares converted into Merger Shares pursuant to Section 1.5 (including any
Company Shares referred to in the last sentence of Section 1.6(a))
(“Certificates”), and Company Stockholders shall not be entitled to any voting
rights, rights to receive any dividends or distributions or other rights as
a
stockholder of the Buyer with respect to any fractional Merger Shares that
would
have otherwise been issued to such Company Stockholder. In lieu of any
fractional Merger Shares that would have otherwise been issued, each Company
Stockholder that would have been entitled to receive a fractional Merger Share
shall, upon proper surrender of such person’s Certificates, receive a cash
payment equal to the closing price per share of the Buyer Common Stock on the
OTCBB on the business day immediately preceding the Closing Date, multiplied
by
the fraction of a share that such Company Stockholder would otherwise be
entitled to receive.
1.8 Options
and Warrants.
(a) As
of the
Effective Time, the Company’s obligations under all unvested options to purchase
Common Shares issued by the Company pursuant to the Company’s stock option
plan (the
“Option Plan”) or otherwise (collectively, “Options”) and the Option Plan,
insofar as it relates to Options outstanding under such Plan immediately after
the Effective Time, shall be assumed by the Buyer. Immediately after the
Effective Time, each unvested Option outstanding immediately prior to the
Effective Time shall be deemed to constitute an option to acquire, on the same
terms and conditions as were applicable under such Option at the Effective
Time,
such number of shares of Buyer Common Stock as is equal to the number of Common
Shares subject to the unexercised portion of such Option multiplied by the
Basic
Common Conversion Ratio (subject to the Lockup Agreement in the form attached
hereto as Exhibit
C
(the
“Lockup Agreement”), with any fraction resulting from such multiplication to be
rounded down to the nearest whole number). The exercise price per share of
each
such assumed Option shall be equal to the exercise price of such Option
immediately prior to the Effective Time, divided by the Basic Common Conversion
Ratio (rounded up to the nearest whole cent). The term, exercisability, vesting
schedule, status as an “incentive stock option” under Section 422 of the
Code, if applicable, and all of the other terms of the Options shall otherwise
remain unchanged.
5
(b) Prior
to
the Closing Date, the Company shall cause the holders of each vested Option
outstanding immediately prior to the Effective Time to exercise for cash or
by
cashless exercise and in each case in accordance with the Option Plan (or if
not
issued pursuant to the Option Plan, pursuant to the applicable option agreement)
all of his or her vested Options, such vested Options to, accordingly, be
cancelled, terminated and extinguished immediately prior to the Effective Time
in exchange for the underlying amount of Common Shares. The Company shall in
its
good faith discretion determine the terms of the cashless exercise provisions
to
be afforded to the holders of Options if and to the extent that Options do
not
contain cashless exercise provisions, provided, that such provisions shall
be in
form and substance agreed by the Buyer.
(c) As
soon
as practicable after the Effective Time, the Buyer or the Surviving Corporation
shall deliver to the holders of non-vested Options that remain outstanding
after
the Effective Time appropriate notices setting forth such holders’ rights
pursuant to such Options, as amended by this Section 1.8,
and the
agreements evidencing such Options shall continue in effect on the same terms
and conditions (subject to the amendments provided for in this
Section 1.8
and such
notice).
(d) The
Buyer
shall take all corporate action necessary to reserve for issuance a sufficient
number of shares of Buyer Common Stock for delivery upon exercise of the Options
assumed in accordance with this Section 1.8.
Within
90 days after the Effective Time, the Buyer shall file a Registration Statement
on Form S-8 (or any successor form) under the Securities Act of 1933 (as
amended, the “Securities Act”) with respect to all shares of Buyer Common Stock
subject to such Options that may be registered on a Form S-8, and shall use
its best efforts to maintain the effectiveness of such Registration Statement
for so long as such Options remain outstanding.
(e) The
Company shall cause the termination, as of the Effective Time, of all unexpired
and exercisable common stock purchase warrants issued by the Company prior
to
the Closing (the “Warrants”) which remain unexercised immediately prior to the
Effective Time.
(f) The
Company shall obtain, prior to the Closing, the consent from each holder of
an
Option or a Warrant to the amendment (in the case of Options) or termination
(in
the case of Warrants) of such Option or Warrant pursuant to this
Section 1.8
(unless
such consent is not required under the terms of the Option Plan or other
applicable agreement, instrument or Option grant).
1.9 Escrow.
6
(a) On
the
Closing Date, the Buyer shall deliver to the Escrow Agent stock certificates
(issued in the name of the Escrow Agent or its nominee) representing the Escrow
Shares for the purpose of securing the indemnification obligations of the
Indemnifying Stockholders (as defined in Section 6.1) set forth in this
Agreement. The Escrow Fund shall be held by the Escrow Agent under the Escrow
Agreement pursuant to the terms thereof. The Escrow Fund shall be held as a
trust fund and shall not be subject to any lien, attachment, trustee process
or
any other judicial process of any creditor of any party, and shall be held
and
disbursed solely for the purposes and in accordance with the terms of the Escrow
Agreement.
(b) The
adoption of this Agreement and the approval of the Merger by the Company
Stockholders shall constitute approval of the Escrow Agreement and of all of
the
arrangements relating thereto, including without limitation the placement of
the
Escrow Shares in escrow and the appointment of the Indemnification
Representative.
(c) Within
five (5) days of the date hereof, the Buyer shall deliver to the Escrow Agent
$1,500,000 in cash to secure Buyers obligations pursuant to Article
VII.
(d) Within
five (5) days of the date hereof, the Company shall deliver to the Escrow Agent
$1,750,000 in cash or, a certificate for Company Shares (issued in the name
of
the Escrow Agent or its nominee) in an amount equal to seven and one-half
percent (7.5%) of the then-issued and outstanding shares of capital stock of
the
Company to secure the Company’s obligations in the event of a termination by the
Buyer or the Company pursuant to Article VII.
1.10 Certificate
of Incorporation and By-laws.
(a) The
Certificate of Incorporation of the Transitory Subsidiary shall continue as
the
Certificate of Incorporation of the Surviving Corporation following the
Effective Time.
(b) The
By-laws of the Surviving Corporation immediately following the Effective Time
shall be the same as the By-laws of the Transitory Subsidiary immediately prior
to the Effective Time.
1.11 No
Further Rights.
From
and after the Effective Time, no Company Shares shall be deemed to be
outstanding, and holders of Certificates shall cease to have any rights with
respect thereto, except as provided herein or by law.
1.12 Closing
of Transfer Books.
At the
Effective Time, the stock transfer books of the Company shall be closed and
no
transfer of Company Shares shall thereafter be made. If, after the Effective
Time, Certificates are presented to the Buyer or the Surviving Corporation,
they
shall be cancelled and exchanged for Merger Shares in accordance with
Section 1.5, subject to Section 1.9 and to applicable law in the case
of Dissenting Shares.
1.13 Basic
Shares.
In the
event that at any time, or from time to time, Basic Shares in excess of those
issued at Closing become issuable pursuant to the terms of this Agreement,
the
Buyer shall promptly issue certificates for such Basic Shares and deliver such
certificates to the Company Stockholders.
7
ARTICLE
II
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
The
Company represents and warrants to the Buyer that the statements contained
in
this Article II are true and correct, except as set forth in the disclosure
schedule provided by the Company to the Buyer on the date hereof and accepted
in
writing by the Buyer (the “Disclosure Schedule”). The Disclosure Schedule shall
be arranged in paragraphs corresponding to the numbered and lettered paragraphs
contained in this Article II, and the disclosures in any paragraph of the
Disclosure Schedule shall qualify only the corresponding paragraph in this
Article II. For purposes of this Article II, the phrase “to the
knowledge of the Company” or any phrase of similar import shall be deemed to
refer to the actual knowledge of the following executive officers of the
Company: Xxxxx Xxxxx and Xxxxx Xxxxx.
2.1 Organization,
Qualification and Corporate Power.
The
Company is a corporation duly organized, validly existing and in corporate
and
tax good standing under the laws of the State of Delaware. The Company is duly
qualified to conduct business and is in corporate and tax good standing under
the laws of each jurisdiction in which the nature of its businesses or the
ownership or leasing of its properties requires such qualification, except
where
the failure to be so qualified or in good standing, individually or in the
aggregate, has not had and would not reasonably be expected to have a Company
Material Adverse Effect (as defined below). The Company has all requisite
corporate power and authority to carry on the businesses in which it is engaged
and to own and use the properties owned and used by it. The Company has
furnished to the Buyer complete and accurate copies of its Certificate of
Incorporation and By-laws. The Company is not in default under or in violation
of any provision of its Certificate of Incorporation or By-laws. For purposes
of
this Agreement, “Company Material Adverse Effect” means a material adverse
effect on the assets, business, condition (financial or otherwise), results
of
operations or future prospects of the Company and the Subsidiaries (as defined
below), taken as a whole, excluding any changes, events or effects that are
attributable to: (i) conditions that materially and adversely affect the general
worldwide economy; (ii) conditions that materially and adversely affect the
industry in which the Company and the Subsidiaries operate; (iii) any effect
arising out of or attributable to the public announcement of the transactions
contemplated by this Agreement or (iv) any effect arising out of or attributable
to any action taken or failed to be taken by the Company or any of its
Subsidiaries at the written request of Buyer or the Transitory Subsidiary.
2.2 Capitalization.
The
capital stock of the Company authorized, issued and outstanding, on a
fully-diluted basis, is set forth in Section 2.2 of the Disclosure Schedule.
Section 2.2 of the Disclosure Schedule sets forth a complete and accurate
list of (i) all stockholders of the Company, indicating the number and
class or series of Company Shares held by each stockholder and (for Company
Shares other than Common Shares) the number of Common Shares (if any) into
which
such Company Shares are convertible, (ii) all outstanding Options and
Warrants, indicating (A) the holder thereof, (B) the number and class
or series of Company Shares subject to each Option and Warrant and (for Company
Shares other than Common Shares) the number of Common Shares (if any) into
which
such Company Shares are convertible, (C) the exercise price, date of grant,
vesting schedule and expiration date for each Option or Warrant, and
(D) any terms regarding the acceleration of vesting, and (iii) all
stock option plans and other stock or equity-related plans of the Company.
All
of the issued and outstanding Company Shares are, and all Company Shares that
may be issued upon exercise of Options or Warrants will be (upon issuance in
accordance with their terms), duly authorized, validly issued, fully paid,
nonassessable and free of all preemptive rights. Other than the Options and
Warrants listed in Section 2.2 of the Disclosure Schedule, there are no
outstanding or authorized options, warrants, rights, agreements or commitments
to which the Company is a party or which are binding upon the Company providing
for the issuance or redemption of any of its capital stock. There are no
outstanding or authorized stock appreciation, phantom stock or similar rights
with respect to the Company. There are no agreements to which the Company is
a
party or by which it is bound with respect to the voting (including without
limitation voting trusts or proxies), registration under the Securities Act,
or
sale or transfer (including without limitation agreements relating to
pre-emptive rights, rights of first refusal, co-sale rights or “drag-along”
rights) of any securities of the Company. To the knowledge of the Company,
there
are no agreements among other parties, to which the Company is not a party
and
by which it is not bound, with respect to the voting (including without
limitation voting trusts or proxies) or sale or transfer (including without
limitation agreements relating to rights of first refusal, co-sale rights or
“drag-along” rights) of any securities of the Company. All of the issued and
outstanding Company Shares were issued in compliance with applicable federal
and
state securities laws.
8
2.3 Authorization
of Transaction.
The
Company has all requisite power and authority to execute and deliver this
Agreement and to perform its obligations hereunder. The execution and delivery
by the Company of this Agreement and, subject to the adoption of this Agreement
and the approval of the Merger by a majority of the votes represented by the
outstanding Company Shares entitled to vote on this Agreement and the Merger
(the “Requisite Stockholder Approval”), the consummation by the Company of the
transactions contemplated hereby have been duly and validly authorized by all
necessary corporate action on the part of the Company. Without limiting the
generality of the foregoing, the Board of Directors of the Company, at a meeting
duly called and held, by the unanimous vote of all directors (i) determined
that the Merger is fair and in the best interests of the Company and its
stockholders, (ii) adopted this Agreement in accordance with the provisions
of the Delaware General Corporation Law, and (iii) directed that this
Agreement and the Merger be submitted to the stockholders of the Company for
their adoption and approval and resolved to recommend that the stockholders
of
Company vote in favor of the adoption of this Agreement and the approval of
the
Merger. This Agreement has been duly and validly executed and delivered by
the
Company and constitutes a valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, subject only
to:
(i) the effects of bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other similar laws relating to or affecting
the
enforcement of creditors’ rights generally and (ii) general equitable principles
(whether considered in a proceeding in equity or at law) (collectively, the
“Equitable Exceptions”).
2.4 Noncontravention.
Subject
to the filing of the Certificate of Merger as required by the Delaware General
Corporation Law, neither the execution and delivery by the Company of this
Agreement, nor the consummation by the Company of the transactions contemplated
hereby, will (a) conflict with or violate any provision of the Certificate
of Incorporation or By-laws of the Company or the charter, By-laws or other
organizational document of any Subsidiary (as defined below), (b) require on
the
part of the Company or any Subsidiary any filing with, or any permit,
authorization, consent or approval of, any court, arbitrational tribunal,
administrative agency or commission or other governmental or regulatory
authority or agency (a “Governmental Entity”), (c) conflict with, result in
a breach of, constitute (with or without due notice or lapse of time or both)
a
default under, result in the acceleration of obligations under, create in any
party the right to terminate, modify or cancel, or require any notice, consent
or waiver under, any contract or instrument to which the Company or any
Subsidiary is a party or by which the Company or any Subsidiary is bound or
to
which any of their assets is subject, (d) result in the imposition of any
Security Interest (as defined below) upon any assets of the Company or any
Subsidiary or (e) violate any material: order, writ, injunction, decree,
statute, rule or regulation applicable to the Company, any Subsidiary or any
of
their properties or assets. For purposes of this Agreement: “Security Interest”
means any mortgage, pledge, security interest, encumbrance, charge or other
lien
(whether arising by contract or by operation of law), other than
(i) mechanic’s, materialmen’s, and similar liens, (ii) liens arising
under worker’s compensation, unemployment insurance, social security,
retirement, and similar legislation, and (iii) liens on goods in transit
incurred pursuant to documentary letters of credit, in each case arising in
the
Ordinary Course of Business (as defined below) of the Company and not material
to the Company; and “Ordinary Course of Business” means the ordinary course of
the Company’s business, consistent with past custom and practice (including with
respect to frequency and amount).
9
2.5 Subsidiaries.
(a) Section 2.5
of the Disclosure Schedule sets forth: (i) the name of each corporation,
partnership, joint venture or other entity in which the Company has, directly
or
indirectly, an equity interest representing 50% or more of the capital stock
thereof or other equity interests therein (individually, a “Subsidiary” and,
collectively, the “Subsidiaries”); (ii) the number and type of outstanding
equity securities of each Subsidiary and a list of the holders thereof;
(iii) the jurisdiction of organization of each Subsidiary; (iv) the
names of the officers and directors of each Subsidiary; and (v) the
jurisdictions in which each Subsidiary is qualified or holds licenses to do
business as a foreign corporation or other entity.
(b) Each
Subsidiary is a corporation duly organized, validly existing and in corporate
and tax good standing under the laws of the jurisdiction of its incorporation.
Each Subsidiary is duly qualified to conduct business and is in corporate and
tax good standing under the laws of each jurisdiction in which the nature of
its
businesses or the ownership or leasing of its properties requires such
qualification, except where the failure to be so qualified or in good standing,
individually or in the aggregate, has not had and would not reasonably be
expected to have a Company Material Adverse Effect. Each Subsidiary has all
requisite power and authority to carry on the businesses in which it is engaged
and to own and use the properties owned and used by it. The Company has
delivered to the Buyer complete and accurate copies of the charter, By-laws
or
other organizational documents of each Subsidiary. No Subsidiary is in default
under or in violation of any provision of its charter, By-laws or other
organizational documents. All of the issued and outstanding shares of capital
stock of each Subsidiary are duly authorized, validly issued, fully paid,
nonassessable and free of preemptive rights. All shares of each Subsidiary
that
are held of record or owned beneficially by either the Company or any Subsidiary
are held or owned free and clear of any restrictions on transfer (other than
restrictions under the Securities Act and state securities laws), claims,
Security Interests, options, warrants, rights, contracts, calls, commitments,
equities and demands. There are no outstanding or authorized options, warrants,
rights, agreements or commitments to which the Company or any Subsidiary is
a
party or which are binding on any of them providing for the issuance,
disposition or acquisition of any capital stock of any Subsidiary. There are
no
outstanding stock appreciation, phantom stock or similar rights with respect
to
any Subsidiary. There are no voting trusts, proxies or other agreements or
understandings with respect to the voting of any capital stock of any
Subsidiary.
10
(c) The
Company does not control directly or indirectly or have any direct or indirect
equity participation or similar interest in any corporation, partnership,
limited liability company, joint venture, trust or other business association
which is not a Subsidiary.
2.6 Financial
Statements.
The
Company has provided to the Buyer (a) the unaudited consolidated balance
sheets and statements of income, changes in stockholders’ equity and cash flows
of the Company as of and for each of the last three fiscal years; and
(b) the unaudited consolidated balance sheet and statements of income,
changes in stockholders’ equity and cash flows as of and for the nine months
ended as of September 30, 2006 (the “Most Recent Balance Sheet Date”). Such
financial statements (collectively, the “Financial Statements”) have been
prepared on an accrual basis and on a consistent basis throughout the periods
covered thereby, fairly present the financial condition, results of operations
and cash flows of the Company and the Subsidiaries as of the respective dates
thereof and for the periods referred to therein and are consistent with the
books and records of the Company and the Subsidiaries; provided,
however,
that
the Financial Statements referred to in clause (b) above are subject
to normal recurring year-end adjustments (which will not be material) and do
not
include footnotes.
2.7 Absence
of Certain Changes.
Since
the Most Recent Balance Sheet Date, (a) there has occurred no event or
development which, individually or in the aggregate, has had, or could
reasonably be expected to have in the future, a Company Material Adverse Effect,
and (b) neither the Company nor any Subsidiary has taken any of the actions
set forth in paragraphs (a) through (n) of Section 4.4.
2.8 Undisclosed
Liabilities.
None of
the Company and its Subsidiaries has any liability (whether known or unknown,
whether absolute or contingent, whether liquidated or unliquidated and whether
due or to become due), except for (a) liabilities shown on the balance
sheet referred to in clause (b) of Section 2.6 (the “Most Recent
Balance Sheet”), (b) liabilities which have arisen since the Most Recent
Balance Sheet Date in the Ordinary Course of Business and (c) contractual
and other liabilities incurred in the Ordinary Course of Business which are
not
required by United States generally accepted accounting principles (“GAAP”) to
be reflected on a balance sheet.
2.9 Tax
Matters.
(a) For
purposes of this Agreement, the following terms shall have the following
meanings:
(i) “Taxes”
means all taxes, charges, fees, levies or other similar assessments or
liabilities, including without limitation income, gross receipts, ad valorem,
premium, value-added, excise, real property, personal property, sales, use,
transfer, withholding, employment, unemployment insurance, social security,
business license, business organization, environmental, workers compensation,
payroll, profits, license, lease, service, service use, severance, stamp,
occupation, windfall profits, customs, duties, franchise and other taxes imposed
by the United States of America or any state, local or foreign government,
or
any agency thereof, or other political subdivision of the United States or
any
such government, and any interest, fines, penalties, assessments or additions
to
tax resulting from, attributable to or incurred in connection with any tax
or
any contest or dispute thereof.
11
(ii) “Tax
Returns” means all reports, returns, declarations, statements or other
information required to be supplied to a taxing authority in connection with
Taxes.
(iii) “Affiliated
Group” means a group of corporations with which the Company or any Subsidiary
has filed (or was required to file) consolidated, combined, unitary or similar
Tax Returns.
(iv) “Affiliated
Period” means any period in which the Company or a Subsidiary was a member of an
Affiliated Group.
(b) Each
of
the Company and the Subsidiaries has filed on a timely basis all Tax Returns
that it was required to file, and all such Tax Returns were complete and
accurate in all material respects. Neither the Company nor any Subsidiary is
or
has ever been a member of a group of corporations with which it has filed (or
been required to file) consolidated, combined or unitary Tax Returns, other
than
a group of which only the Company and the Subsidiaries are or were members.
Each
of the Company and the Subsidiaries has paid on a timely basis all Taxes that
were due and payable. The unpaid Taxes of the Company and the Subsidiaries
for
tax periods through the Most Recent Balance Sheet Date do not exceed the
accruals and reserves for Taxes (excluding accruals and reserves for deferred
Taxes established to reflect timing differences between book and Tax income)
set
forth on the Most Recent Balance Sheet. Neither the Company nor any Subsidiary
has any actual or potential liability for any Tax obligation of any taxpayer
(including without limitation any affiliated group of corporations or other
entities that included the Company or any Subsidiary during a prior period)
other than the Company and the Subsidiaries. All Taxes that the Company or
any
Subsidiary is or was required by law to withhold or collect have been duly
withheld or collected and, to the extent required, have been paid to the proper
Governmental Entity.
(c) The
Company has delivered to the Buyer complete and accurate copies of all federal
income Tax Returns, examination reports and statements of deficiencies assessed
against or agreed to by the Company or any Subsidiary prior to the Effective
Time. The federal income Tax Returns of the Company and each Subsidiary have
been audited by the Internal Revenue Service (“IRS”) or are closed by the
applicable statute of limitations for all taxable years through the taxable
year
specified in Section 2.9(c) of the Disclosure Schedule. No examination or
audit of any Tax Return of the Company or any Subsidiary by any Governmental
Entity is currently in progress or, to the knowledge of the Company, threatened
or contemplated. Neither the Company nor any Subsidiary has been informed by
any
jurisdiction that the jurisdiction believes that the Company or Subsidiary
was
required to file any Tax Return that was not filed. Neither the Company nor
any
Subsidiary has waived any statute of limitations with respect to Taxes or agreed
to an extension of time with respect to a Tax assessment or
deficiency.
12
(d) Neither
the Company nor any Subsidiary: (i) is a “consenting corporation” within
the meaning of Section 341(f) of the Code, and none of the assets of the
Company or the Subsidiaries are subject to an election under Section 341(f)
of the Code; (ii) has been a United States real property holding
corporation within the meaning of Section 897(c)(2) of the Code during the
applicable period specified in Section 897(c)(l)(A)(ii) of the Code;
(iii) except as set forth on Section 2.9(d) of the Disclosure Schedule, has
made any payments, is obligated to make any payments, or is a party to any
agreement that could obligate it to make any payments that may be treated as
an
“excess parachute payment” under Section 280G of the Code; (iv) has
any actual or potential liability for any Taxes of any person (other than the
Company and its Subsidiaries) under Treasury Regulation Section 1.1502-6
(or any similar provision of federal, state, local, or foreign law), or as
a
transferee or successor, by contract, or otherwise; or (v) is or has been
required to make a basis reduction pursuant to Treasury Regulation
Section 1.1502-20(b) or Treasury Regulation
Section 1.337(d)-2(b).
(e) None
of
the assets of the Company or any Subsidiary: (i) is property that is
required to be treated as being owned by any other person pursuant to the
provisions of former Section 168(f)(8) of the Code; (ii) is
“tax-exempt use property” within the meaning of Section 168(h) of the Code;
or (iii) directly or indirectly secures any debt the interest on which is
tax exempt under Section 103(a) of the Code.
(f) Neither
the Company nor any Subsidiary has undergone a change in its method of
accounting resulting in an adjustment to its taxable income pursuant to
Section 481 of the Code.
(g) No
state
or federal “net operating loss” or any capital losses or credits of the Company
or any Subsidiary determined as of the period underlying any Tax Return of
the
Company prior to the Closing Date is subject to limitation on its use pursuant
to the Code or Treasury Regulations thereunder (including without limitation
Section 382 of the Code) or relevant provisions of state law as a result of
any
“ownership change” within the meaning of Section 382(g) of the Code or
comparable provisions of any state law or any other change in the ownership
of
stock of the Company or any Subsidiary occurring prior to the Closing Date.
(h) Neither
the Company nor any Subsidiary has at any time participated in any "reportable
transaction" within the meaning of Treasury Regulation Sections 1.6011-(b),
made
any disclosure or protective disclosure pursuant to section 6011 of the Code
or
the Treasury Regulations thereunder, or received any communication from the
IRS
or any state or local taxing authority with respect to any transaction which
the
IRS or any such state or local taxing authority has asserted is or may be a
"reportable transaction."
2.10 Assets.
Each of
the Company and the Subsidiaries owns or leases all tangible assets necessary
for the conduct of its businesses as presently conducted. Each such material
tangible asset is free from material defects, has been maintained in accordance
with normal industry practice, is in good operating condition and repair
(subject to normal wear and tear) and is suitable for the purposes for which
it
presently is used. No asset of the Company or any Subsidiary (tangible or
intangible) is subject to any Security Interest.
13
2.11 Owned
Real Property.
Neither
the Company nor any Subsidiary or any of their respective predecessor entities
owns, or at any time owned, any real property.
2.12 Real
Property Leases.
Section 2.12 of the Disclosure Schedule lists all real property leased or
subleased to or by the Company or any Subsidiary and lists the term of such
lease, any extension and expansion options, and the rent payable thereunder.
The
Company has delivered to the Buyer complete and accurate copies of the leases
and subleases listed in Section 2.12 of the Disclosure Schedule. With
respect to each lease and sublease listed in Section 2.12 of the Disclosure
Schedule:
(a) the
lease
or sublease is legal, valid, binding, enforceable and in full force and
effect;
(b) the
lease
or sublease will continue to be legal, valid, binding, enforceable and in full
force and effect immediately following the Closing in accordance with the terms
thereof as in effect immediately prior to the Closing;
(c) neither
the Company nor any Subsidiary nor, to the knowledge of the Company, any other
party, is in breach or violation of, or default under, any such lease or
sublease, and no event has occurred, is pending or, to the knowledge of the
Company, is threatened, which, after the giving of notice, with lapse of time,
or otherwise, would constitute a breach or default by the Company or any
Subsidiary or, to the knowledge of the Company, any other party under such
lease
or sublease;
(d) neither
the Company nor any Subsidiary has assigned, transferred, conveyed, mortgaged,
deeded in trust or encumbered any interest in the leasehold or subleasehold;
and
(e) the
Company is not aware of any Security Interest, easement, covenant or other
restriction applicable to the real property subject to such lease, except for
recorded easements, covenants and other restrictions which do not materially
impair the current uses or the occupancy by the Company or a Subsidiary of
the
property subject thereto.
2.13 Intellectual
Property.
(a) Each
of
the Company and the Subsidiaries owns or has the right to use all Intellectual
Property (as defined below) necessary (i) to provide the services provided
by
the Company or the Subsidiaries to other parties, (together, the “Customer
Deliverables”) and (ii) to operate the internal systems of the Company or the
Subsidiaries that are material to its business or operations, including, without
limitation, computer hardware systems, software applications and embedded
systems (the “Internal Systems”; the Intellectual Property owned by or licensed
to the Company or the Subsidiaries and incorporated in or underlying the
Customer Deliverables or the Internal Systems is referred to herein as the
“Company Intellectual Property”). Each item of Company Intellectual Property
will be owned or available for use by the Surviving Corporation immediately
following the Closing on substantially identical terms and conditions as it
was
immediately prior to the Closing. The Company or the appropriate Subsidiary
has
taken all reasonable measures to protect the proprietary nature of each item
of
Company Intellectual Property. To the knowledge of the Company, except for
the
works of authorship uploaded by the Company’s users to the websites hosted by
the Company or in the course of services provided by the Company and works
that
are the subject of alleged copyright infringement as alleged in the Record
Label
Litigation (as defined in Section 2.18), (a) no other person or entity has
any
rights to any of the Company Intellectual Property owned by the Company or
a
Subsidiary (except pursuant to agreements or licenses specified in Section
2.13(c) of the Disclosure Schedule), (b) no Company Intellectual Property
infringes the rights of any other Person, and (c) no other person or entity
is
infringing, violating or misappropriating any of the Company Intellectual
Property. For purposes of this Agreement, “Intellectual Property” means all (i)
patents and patent applications, (ii) copyrights and registrations thereof,
(iii) mask works and registrations and applications for registration thereof,
(iv) computer software, data and documentation, (v) trade secrets and
confidential business information, whether patentable or unpatentable and
whether or not reduced to practice, know-how, manufacturing and production
processes and techniques, research and development information, copyrightable
works, financial, marketing and business data, pricing and cost information,
business and marketing plans and customer and supplier lists and information,
(vi) trademarks, service marks, trade names, domain names and applications
and
registrations therefor and (vii) other proprietary rights relating to any of
the
foregoing. Section 2.13(a) of the Disclosure Schedule lists each patent, patent
application, copyright registration or application therefor, mask work
registration or application therefor, and trademark, service xxxx and domain
name registration or application therefor of the Company or any
Subsidiary.
14
(b) None
of
the Customer Deliverables, or the marketing, distribution, provision or use
thereof by the Company, infringes or violates, or constitutes a misappropriation
of, any Intellectual Property rights of any person or entity. None of the
Internal Systems, or the use thereof by the Company, infringes or violates,
or
constitutes a misappropriation of, any Intellectual Property rights of any
person or entity. Section 2.13(b) of the Disclosure Schedule lists any
complaint, claim or notice, or written threat thereof, received by the Company
or any Subsidiary alleging any such infringement, violation or misappropriation;
and the Company has provided to the Buyer complete and accurate copies of all
written documentation in the possession of the Company or any Subsidiary
relating to any such complaint, claim, notice or threat. The Company has
provided to the Buyer complete and accurate copies of all written documentation
in the Company’s possession relating to claims or disputes known to the Company
concerning any Company Intellectual Property.
(c) Section 2.13(c)
of the Disclosure Schedule identifies each license or other agreement (or type
of license or other agreement) pursuant to which the Company or a Subsidiary
has
licensed, distributed or otherwise granted any rights to any third party with
respect to, any Company Intellectual Property.
(d) Section 2.13(d)
of the Disclosure Schedule identifies each item of Company Intellectual Property
that is owned by a party other than the Company or a Subsidiary, and the license
or agreement pursuant to which the Company or a Subsidiary uses it (excluding
off-the-shelf software programs licensed by the Company pursuant to “shrink
wrap” licenses).
15
(e) Neither
the Company nor any Subsidiary has disclosed the source code for any of the
software owned by the Company or a Subsidiary (the “Software”) or other
confidential information constituting, embodied in or pertaining to the Software
to any person or entity, except pursuant to the agreements listed in
Section 2.13(e) of the Disclosure Schedule, and the Company has taken
reasonable measure to prevent disclosure of such source code.
(f) All
of
the copyrightable materials (including Software) except for works of authorship
uploaded to any Company websites by the Company’s users thereof in the course of
using the Company’s websites or other services (“Customer
Provided Content”)
incorporated in or bundled with the Customer Deliverables have been created
by
employees of the Company or a Subsidiary within the scope of their employment by
the Company or a Subsidiary or by independent contractors of the Company or
a
Subsidiary who have executed agreements expressly assigning all right, title
and
interest in such copyrightable materials to the Company or a Subsidiary. No
portion of such copyrightable materials was jointly developed with any third
party.
(g) To
the
knowledge of the Company, the Customer Deliverables and the Internal Systems
are
free from significant defects or programming errors and conform in all material
respects to the written documentation and specifications therefor.
2.14 Contracts.
(a) Section 2.14(a)
of the Disclosure Schedule lists the following agreements (written or oral)
to
which the Company or any Subsidiary is a party as of the date of this
Agreement:
(i) any
agreement (or group of related agreements) for the lease of personal property
from or to third parties providing for lease payments in excess of $10,000
per
annum or having a remaining term longer than one year;
(ii) any
agreement (or group of related agreements) for the purchase or sale of products
or for the furnishing or receipt of services (A) which calls for
performance over a period of more than one year, (B) which involves more
than the sum of $10,000, or (C) in which the Company or any Subsidiary has
granted licensing rights, “most favored nation” pricing provisions or marketing
or distribution rights relating to any products or services or territory or
has
agreed to purchase a minimum quantity of goods or services or has agreed to
purchase goods or services exclusively from a certain party;
(iii) any
agreement establishing a partnership or joint venture;
(iv) any
agreement (or group of related agreements) under which it has created, incurred,
assumed or guaranteed (or may create, incur, assume or guarantee) indebtedness
(including capital lease obligations but not including trade payables incurred
in the Ordinary Course of Business) involving more than $10,000 or under which
it has imposed (or may impose) a Security Interest on any of its assets,
tangible or intangible;
(v) any
agreement by which the Company is bound by any noncompetition or nondisclosure
covenant other than nondisclosure agreements entered into in the Ordinary Course
of Business;
16
(vi) any
employment or consulting agreement between the Company or any Subsidiary and
any
employee or consultant;
(vii) any
material agreement involving any current officer, director or stockholder of
the
Company or any affiliate (an “Affiliate”), as defined in Rule 12b-2 under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), thereof
not otherwise disclosed pursuant to this Section 2.14;
(viii) any
agreement under which the consequences of a default or termination would
reasonably be expected to have a Company Material Adverse Effect;
(ix) any
agreement which contains any provisions requiring the Company or any Subsidiary
to indemnify any other party thereto (excluding indemnities contained in
agreements for the purchase, sale or license of products entered into in the
Ordinary Course of Business); and
(x) any
other
agreement (or group of related agreements) either involving more than $10,000
or
not entered into in the Ordinary Course of Business.
(b) The
Company has delivered to the Buyer a complete and accurate copy of each
agreement listed in Section 2.13 or Section 2.14 of the Disclosure
Schedule. With respect to each agreement so listed: (i) the agreement is
legal, valid, binding and enforceable and in full force and effect;
(ii) the agreement will continue to be legal, valid, binding and
enforceable and in full force and effect immediately following the Closing
in
accordance with the terms thereof as in effect immediately prior to the Closing;
and (iii) neither the Company nor any Subsidiary nor, to the knowledge of
the Company, any other party, is in material breach or material violation of,
or
default under, any such agreement, and no event has occurred, is pending or,
to
the knowledge of the Company, is threatened, which, after the giving of notice,
with lapse of time, or otherwise, would constitute a material breach or material
default by the Company or any Subsidiary or, to the knowledge of the Company,
any other party under such contract.
2.15 Accounts
Receivable.
All
accounts receivable of the Company and the Subsidiaries reflected on the Most
Recent Balance Sheet are valid receivables subject to no setoffs or
counterclaims and are current and collectible (within 90 days after the date
on
which it first became due and payable), net of the applicable reserve for bad
debts on the Most Recent Balance Sheet. All accounts receivable reflected in
the
financial or accounting records of the Company that have arisen since the Most
Recent Balance Sheet Date are valid receivables subject to no setoffs or
counterclaims and are collectible (within 90 days after the date on which it
first became due and payable), net of a reserve for bad debts in an amount
proportionate to the reserve shown on the Most Recent Balance
Sheet.
2.16 Powers
of Attorney.
There
are no outstanding powers of attorney executed on behalf of the Company or
any
Subsidiary.
2.17 Insurance.
Section 2.17 of the Disclosure Schedule lists each insurance policy
(including fire, theft, casualty, general liability, workers compensation,
business interruption, environmental, product liability and automobile insurance
policies and bond and surety arrangements) to which the Company or any
Subsidiary is a party. Such insurance policies are of the type and in amounts
customarily carried by organizations conducting businesses or owning assets
similar to those of the Company and the Subsidiaries. There is no material
claim
pending under any such policy as to which coverage has been questioned, denied
or disputed by the underwriter of such policy. All premiums due and payable
under all such policies have been paid, neither the Company nor any Subsidiary
may be liable for retroactive premiums or similar payments, and the Company
and
the Subsidiaries are otherwise in compliance in all material respects with
the
terms of such policies. The Company has no knowledge of any threatened
termination of, or material premium increase with respect to, any such policy.
Each such policy will continue to be enforceable and in full force and effect
immediately following the Closing in accordance with the terms thereof as in
effect immediately prior to the Closing.
17
2.18 Litigation. Other
than the Copyright infringement lawsuits described as UMG Recordings, Inc.,
et
al v. Bolt, Inc., et al, USDC Case No. CV06-Q6577-AHM, pending in the Federal
District Court for the Central District of California and all comparable claims
that may be made by any major or independent record labels or publishers
(together, the “Record Label Litigation”) and Xxx.Xxxxxxx.xxx, Inc. v. Bolt,
Inc., pending in the Superior Court o the State of California (the “Zeocast
Litigation”), as of the date of this Agreement, there is no action, suit,
proceeding, claim, arbitration or investigation before any Governmental Entity
or before any arbitrator which is pending or has been threatened in writing
against the Company or any Subsidiary (a “Legal Proceeding”) which (a) seeks
either damages in excess of $10,000 or equitable relief, (b) in any manner
challenges or seeks to prevent, enjoin, alter or delay the transactions
contemplated by this Agreement, or (c) if determined adversely to the Company
or
such Subsidiary, would have, individually or in the aggregate, a Company
Material Adverse Effect.
2.19 Warranties.
No
product or service manufactured, sold, leased, licensed or delivered by the
Company or any Subsidiary is subject to any guaranty, warranty, right of return,
right of credit or other indemnity other than (i) the applicable standard
terms and conditions of sale or lease of the Company or the appropriate
Subsidiary, which are set forth in Section 2.19 of the Disclosure Schedule
and (ii) manufacturers’ warranties for which neither the Company nor any
Subsidiary has any liability. Section 2.19 of the Disclosure Schedule sets
forth the aggregate expenses incurred by the Company and the Subsidiaries in
fulfilling their obligations under their guaranty, warranty, right of return
and
indemnity provisions during each of the fiscal years and the interim period
covered by the Financial Statements; and the Company does not know of any reason
why such expenses should significantly increase as a percentage of sales in
the
future.
2.20 Employees.
(a) Section 2.20(a)
of the Disclosure Schedule contains a list of all employees of the Company
and
each Subsidiary whose annual rate of compensation exceeds $50,000 per year,
along with the position and the annual rate of compensation of each such person.
Section 2.20(a) of the Disclosure Schedule contains a list of all current
and past employees of the Company or any Subsidiary who are a party to
non-competition, confidentiality and/or assignments of inventions agreements
with the Company or any Subsidiary; copies of such agreements have previously
been delivered to the Buyer. To the knowledge of the Company, no key employee
or
group of employees has any plans to terminate employment with the Company or
any
Subsidiary.
18
(b) Neither
the Company nor any Subsidiary is a party to or bound by any collective
bargaining agreement, nor has any of them experienced any strikes, grievances,
claims of unfair labor practices or other collective bargaining disputes. The
Company has no knowledge of any organizational effort made or threatened, either
currently or within the past two years, by or on behalf of any labor union
with
respect to employees of the Company or any Subsidiary.
2.21 Employee
Benefits.
(a) For
purposes of this Agreement, the following terms shall have the following
meanings:
(i) “Employee
Benefit Plan” means any “employee pension benefit plan” (as defined in
Section 3(2) of ERISA), any “employee welfare benefit plan” (as defined in
Section 3(1) of ERISA), and any other written or oral plan, agreement or
arrangement involving direct or indirect compensation, including without
limitation insurance coverage, severance benefits, disability benefits, deferred
compensation, bonuses, stock options, stock purchase, phantom stock, stock
appreciation or other forms of incentive compensation or post-retirement
compensation or other benefits.
(ii) “ERISA”
means the Employee Retirement Income Security Act of 1974, as
amended.
(iii) “ERISA
Affiliate” means any entity which is a member of (1) a controlled group of
corporations (as defined in Section 414(b) of the Code), (2) a group
of trades or businesses under common control (as defined in Section 414(c)
of the Code), or (3) an affiliated service group (as defined under
Section 414(m) of the Code or the regulations under Section 414(o) of
the Code), any of which includes or included the Company or a
Subsidiary.
(b) Section 2.21(b)
of the Disclosure Schedule contains a complete and accurate list of all Employee
Benefit Plans maintained, or contributed to, by the Company, any Subsidiary
or
any ERISA Affiliate. Complete and accurate copies of (i) all Employee
Benefit Plans which have been reduced to writing, (ii) written summaries of
all unwritten Employee Benefit Plans, (iii) all related trust agreements,
insurance contracts and summary plan descriptions, and (iv) all annual
reports filed on IRS Form 5500 and (for all funded plans) all plan financial
statements for the last three plan years for each Employee Benefit Plan, have
been delivered to the Buyer. Each Employee Benefit Plan has been administered
in
all material respects in accordance with its terms and each of the Company,
the
Subsidiaries and the ERISA Affiliates has in all material respects met its
obligations with respect to such Employee Benefit Plan and has made all required
contributions thereto. The Company, each Subsidiary, each ERISA Affiliate and
each Employee Benefit Plan are in compliance in all material respects with
the
currently applicable provisions of ERISA and the Code and the regulations
thereunder (including without limitation Section 4980 B of the Code,
Subtitle K, Chapter 100 of the Code and Sections 601 through 608 and
Section 701 et seq. of ERISA). All filings and reports as to each Employee
Benefit Plan required to have been submitted to the IRS or to the United States
Department of Labor have been duly submitted.
19
(c) There
are
no Legal Proceedings (except claims for benefits payable in the normal operation
of the Employee Benefit Plans and proceedings with respect to qualified domestic
relations orders) against or involving any Employee Benefit Plan or asserting
any rights or claims to benefits under any Employee Benefit Plan that could
give
rise to any material liability.
(d) Except
for Employee Benefit Plans using prototype or other plan documents which are
pre-approved by the IRS, all the Employee Benefit Plans listed on Section
2.21(b) of the Disclosure Schedule that are intended to be qualified under
Section 401(a) of the Code have received determination letters from the IRS
to the effect that such Employee Benefit Plans are qualified and the plans
and
the trusts related thereto are exempt from federal income taxes under Section
501(a) of the Code, no such determination letter has been revoked and revocation
has not been threatened, and no act or omission has occurred, that would
adversely affect its qualification or materially increase its cost. All of
the
Employee Benefit Plans listed on Section 2.21(b) of the Disclosure Schedule
that
are intended to be qualified under Section 401(a) of the Code, and that have
not
received determination letters from the IRS, use plan and trust documents that
have been pre-approved by the IRS, evidenced by the IRS’s issuance of an opinion
letter to the sponsor of such plan and trust documents. Copies of each such
determination letter and opinion letter have previously been delivered to the
Buyer. Each Employee Benefit Plan listed on Section 2.21(b) of the Disclosure
Schedule which is required to satisfy Section 401(k)(3) or
Section 401(m)(2) of the Code has been tested for compliance with, and
satisfies the requirements of, Section 401(k)(3) and Section 401(m)(2)
of the Code for each plan year ending prior to the Closing Date.
(e) Neither
the Company, any Subsidiary, nor any ERISA Affiliate has ever maintained an
Employee Benefit Plan subject to Section 412 of the Code or Title IV of
ERISA.
(f) At
no
time has the Company, any Subsidiary or any ERISA Affiliate been obligated
to
contribute to any “multiemployer plan” (as defined in Section 4001(a)(3) of
ERISA).
(g) There
are
no material unfunded obligations under any Employee Benefit Plan listed on
Section 2.21(b) of the Disclosure Schedule providing benefits after termination
of employment to any employee of the Company or any Subsidiary (or to any
beneficiary of any such employee), including but not limited to retiree health
coverage and deferred compensation, but excluding severance benefits identified
in Section 2.21(g) of the Disclosure Schedule, continuation of health
coverage required to be continued under Section 4980B of the Code or other
applicable law and insurance conversion privileges under state law. The assets
of each Employee Benefit Plan listed on Section 2.21(b) of the Disclosure
Schedule which is funded are reported at their fair market value on the books
and records of such Employee Benefit Plan.
(h) To
the
knowledge of the Company, no act or omission has occurred and no condition
exists with respect to any Employee Benefit Plan listed on Section 2.21(b)
of
the Disclosure Schedule that would subject the Company, any Subsidiary or any
ERISA Affiliate to (i) any material fine, penalty, tax or liability of any
kind
imposed under ERISA or the Code or (ii) any contractual indemnification or
contribution obligation protecting any fiduciary, insurer or service provider
with respect to any such Employee Benefit Plan.
20
(i) No
Employee Benefit Plan listed on Section 2.21(b) of the Disclosure Schedule
is
funded by, associated with or related to a “voluntary employee’s beneficiary
association” within the meaning of Section 501(c)(9) of the
Code.
(j) Each
Employee Benefit Plan listed on Section 2.21(b) of the Disclosure Schedule
may
be amended or terminated by the Company or by a Subsidiary or an ERISA
Affiliate, as the case may be, at any time without liability, except as set
forth in such plan and described in Section 2.21(j) of the Disclosure
Schedule or as required by law, to the Company or any Subsidiary or ERISA
Affiliate as a result thereof and no summary plan description or other written
communication distributed generally to employees with respect to any such
Employee Benefit Plan by its terms prohibits the Company, any Subsidiary or
any
ERISA Affiliate from amending or terminating such Employee Benefit
Plan.
(k) Section 2.21(k)
of the Disclosure Schedule discloses each: (i) agreement with any
stockholder, director, executive officer or other key employee of the Company
or
any Subsidiary (A) the benefits of which are contingent, or the terms of
which are materially altered, upon the occurrence of a transaction involving
the
Company or any Subsidiary of the nature of any of the transactions contemplated
by this Agreement, (B) providing any term of employment or compensation
guarantee or (C) providing severance benefits or other benefits after the
termination of employment of such director, executive officer or key employee;
(ii) agreement, plan or arrangement under which any person may receive
payments from the Company or any Subsidiary that may be subject to the tax
imposed by Section 4999 of the Code or included in the determination of
such person’s “parachute payment” under Section 280G of the Code; and
(iii) agreement or plan binding the Company or any Subsidiary, including
without limitation any stock option plan, stock appreciation right plan,
restricted stock plan, stock purchase plan, severance benefit plan or other
Employee Benefit Plan listed on Section 2.21(b) of the Disclosure Schedule,
any
of the benefits of which will be increased, or the vesting of the benefits
of
which will be accelerated, by the occurrence of any of the transactions
contemplated by this Agreement or the value of any of the benefits of which
will
be calculated on the basis of any of the transactions contemplated by this
Agreement.
(l) Section 2.21(l)
of the Disclosure Schedule sets forth the policy of the Company and any
Subsidiary with respect to accrued vacation, accrued sick time and earned time
off and the amount of such liabilities as of December 31, 2006.
2.22 Environmental
Matters.
(a) Except
as
would have a Company Material Adverse Effect, each of the Company and the
Subsidiaries has complied with all applicable Environmental Laws (as defined
below). There is no pending or, to the knowledge of the Company, threatened
civil or criminal litigation, written notice of violation, formal administrative
proceeding, or investigation, inquiry or information request by any Governmental
Entity, relating to any Environmental Law involving the Company or any
Subsidiary. For purposes of this Agreement, “Environmental Law” means any
federal, state or local law, statute, rule or regulation or the common law
relating to the environment or occupational health and safety, including without
limitation any statute, regulation, administrative decision or order pertaining
to (i) treatment, storage, disposal, generation and transportation of
industrial, toxic or hazardous materials or substances or solid or hazardous
waste; (ii) air, water and noise pollution; (iii) groundwater and soil
contamination; (iv) the release or threatened release into the environment
of industrial, toxic or hazardous materials or substances, or solid or hazardous
waste, including without limitation emissions, discharges, injections, spills,
escapes or dumping of pollutants, contaminants or chemicals; (v) the
protection of wild life, marine life and wetlands, including without limitation
all endangered and threatened species; (vi) storage tanks, vessels,
containers, abandoned or discarded barrels, and other closed receptacles;
(vii) health and safety of employees and other persons; and
(viii) manufacturing, processing, using, distributing, treating, storing,
disposing, transporting or handling of materials regulated under any law as
pollutants, contaminants, toxic or hazardous materials or substances or oil
or
petroleum products or solid or hazardous waste. As used above, the terms
“release” and “environment” shall have the meaning set forth in the
Comprehensive Environmental Response, Compensation and Liability Act of 1980,
as
amended (“CERCLA”).
21
(b) To
the
knowledge of the Company, there have been no releases of any Materials of
Environmental Concern (as defined below) into the environment at any parcel
of
real property or any facility formerly or currently owned, operated or
controlled by the Company or a Subsidiary. With respect to any such releases
of
Materials of Environmental Concern, the Company or such Subsidiary has given
all
required notices to Governmental Entities (copies of which have been provided
to
the Buyer). The Company is not aware of any releases of Materials of
Environmental Concern at parcels of real property or facilities other than
those
owned, operated or controlled by the Company or a Subsidiary that could
reasonably be expected to have an impact on the real property or facilities
owned, operated or controlled by the Company or a Subsidiary. For purposes
of
this Agreement, “Materials of Environmental Concern” means any chemicals,
pollutants or contaminants, hazardous substances (as such term is defined under
CERCLA), solid wastes and hazardous wastes (as such terms are defined under
the
Resource Conservation and Recovery Act), toxic materials, oil or petroleum
and
petroleum products or any other material subject to regulation under any
Environmental Law.
(c) Set
forth
in Section 2.22(c) of the Disclosure Schedule is a list of all documents
(whether in hard copy or electronic form) that contain any environmental
reports, investigations and audits relating to premises currently or previously
owned or operated by the Company or a Subsidiary (whether conducted by or on
behalf of the Company or a Subsidiary or a third party, and whether done at
the
initiative of the Company or a Subsidiary or directed by a Governmental Entity
or other third party) which the Company has possession of or access to. A
complete and accurate copy of each such document has been provided to the
Buyer.
(d) The
Company is not aware of any material environmental liability of any solid or
hazardous waste transporter or treatment, storage or disposal facility that
has
been used by the Company or any Subsidiary.
2.23 Legal
Compliance.
Each of
the Company and the Subsidiaries, and the conduct and operations of their
respective businesses, are in compliance with each applicable law (including
rules and regulations thereunder) of any federal, state, local or foreign
government, or any Governmental Entity, except for any violations or defaults
that, individually or in the aggregate, have not had and would not reasonably
be
expected to have a Company Material Adverse Effect.
22
2.24 Customers
and Suppliers.
Section 2.24 of the Disclosure Schedule sets forth a list of (a) each
customer that accounted for more than 1% of the consolidated revenues of the
Company during the last full fiscal year or the interim period through the
Most
Recent Balance Sheet Date and the amount of revenues accounted for by such
customer during each such period and (b) each supplier that is the sole
supplier of any significant product to the Company or a Subsidiary. No such
customer or supplier has indicated within the past year that it will stop,
or
decrease the rate of, buying products or supplying products, as applicable,
to
the Company or any Subsidiary. No unfilled customer order or commitment
obligating the Company or any Subsidiary to process, manufacture or deliver
products or perform services will result in a loss to the Company or any
Subsidiary upon completion of performance. No purchase order or commitment
of
the Company or any Subsidiary is in excess of normal requirements, nor are
prices provided therein in excess of current market prices for the products
or
services to be provided thereunder.
2.25 Permits.
Section 2.25 of the Disclosure Schedule sets forth a list of all permits,
licenses, registrations, certificates, orders or approvals from any Governmental
Entity (including without limitation those issued or required under
Environmental Laws and those relating to the occupancy or use of owned or leased
real property) (“Permits”) issued to or held by the Company or any Subsidiary.
Such listed Permits are the only Permits that are required for the Company
and
the Subsidiaries to conduct their respective businesses as presently conducted,
except for those the absence of which, individually or in the aggregate, have
not had and would not reasonably be expected to have a Company Material Adverse
Effect. Each such Permit is in full force and effect and, to the knowledge
of
the Company, no suspension or cancellation of such Permit is threatened and
there is no basis for believing that such Permit will not be renewable upon
expiration. Each such Permit will continue in full force and effect immediately
following the Closing.
2.26 Certain
Business Relationships With Affiliates.
No
Affiliate of the Company or of any Subsidiary (a) owns any property or
right, tangible or intangible, which is used in the business of the Company
or
any Subsidiary, (b) has any claim or cause of action against the Company or
any Subsidiary, or (c) owes any money to, or is owed any money by, the
Company or any Subsidiary. Section 2.26 of the Disclosure Schedule
describes any transactions or relationships between the Company or a Subsidiary
and any Affiliate thereof which have occurred or existed since the beginning
of
the time period covered by the Financial Statements.
2.27 Brokers’
Fees.
Neither
the Company nor any Subsidiary has any liability or obligation to pay any fees
or commissions to any broker, finder or agent with respect to the transactions
contemplated by this Agreement, other than the fees payable to Savvian,
LLC.
2.28 Books
and Records.
The
minute books and other similar records of the Company and each Subsidiary
contain complete and accurate records of all actions taken at any meetings
of
the Company’s or such Subsidiary’s stockholders, Board of Directors or any
committee thereof and of all written consents executed in lieu of the holding
of
any such meeting. The books and records of the Company and each Subsidiary
accurately reflect in all material respects the assets, liabilities, business,
financial condition and results of operations of the Company or such Subsidiary
and have been maintained in accordance with good business and bookkeeping
practices.
23
2.29 Certain
Business Practices
. To the
Company’s knowledge, neither the Company, nor any Subsidiary, nor any director,
officer, agent or employee of the Company or any Subsidiary (in their capacities
as such) has (i) used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees,
to
foreign or domestic political parties or campaigns or violated any provision
of
the Foreign Corrupt Practices Act of 1977 to the extent applicable to the
Company or any Subsidiary or (iii) made any other unlawful payment. Neither
the
Company, nor any Subsidiary, nor any director, officer, agent or employee of
the
Company or any Subsidiary (nor any Person acting on behalf of any of the
foregoing, but solely in his or her capacity as a director, officer, employee
or
agent of the Company) has, since January 1, 2000, directly or indirectly, given
or agreed to give any gift or similar benefit in any material amount to any
customer, supplier, governmental employee or other Person who is or may be
in a
position to help or hinder the Company or any Subsidiary or assist the Company
or any Subsidiary in connection with any actual or proposed transaction, which,
if not given could reasonably be expected to have had an adverse effect on
the
Company or any Subsidiary, or which, if not continued in the future, could
reasonably be expected to adversely affect the business or prospects of the
Company or any Subsidiary or that could reasonably be expected to subject the
Company to penalty in any private or governmental litigation or proceeding.
To
the knowledge of Company, there is no material violation of the laundering
statutes of the States in which the Company or the Subsidiaries do business,
applicable to the Company’s business, and the Laws of the United States
applicable to the Company’s business, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered
or
enforced by any governmental authority (collectively, the “Money Laundering
Laws”) that are applicable to the Company’s business, and no criminal or
material civil Action involving the Company or any Subsidiary with respect
to
the Money Laundering Laws is pending or, to the knowledge of the Company,
threatened.
2.30 Disclosure.
No
representation or warranty by the Company contained in this Agreement, and no
statement contained in the Disclosure Schedule or any other document,
certificate or other instrument delivered or to be delivered by or on behalf
of
the Company pursuant to this Agreement, contains or will contain any untrue
statement of a material fact or omits or will omit to state any material fact
necessary, in light of the circumstances under which it was or will be made,
in
order to make the statements herein or therein not misleading.
ARTICLE
III
REPRESENTATIONS
AND WARRANTIES OF THE BUYER
AND
THE TRANSITORY SUBSIDIARY
Each
of
the Buyer and the Transitory Subsidiary represents and warrants to the Company
as follows (such representations and warranties being made to and for the
benefit of the Company and the Indemnifying Stockholders (as defined in Section
6.1) only and not for the benefit of any other Person, and no other Person
may
rely on the accuracy of the foregoing representations and warranties for any
purpose whatsoever):
24
3.1 Organization,
Qualification and Corporate Power.
Each of
the Buyer and the Transitory Subsidiary is a corporation duly organized, validly
existing and in good standing under the laws of the state of its incorporation.
The Buyer is duly qualified to conduct business and is in corporate and tax
good
standing under the laws of each jurisdiction in which the nature of its
businesses or the ownership or leasing of its properties requires such
qualification, except where the failure to be so qualified or in good standing
would not have a Buyer Material Adverse Effect (as defined below). The Buyer
has
all requisite corporate power and authority to carry on the businesses in which
it is engaged and to own and use the properties owned and used by it. The Buyer
has furnished or made available to the Company complete and accurate copies
of
its Certificate of Incorporation and By-laws. For purposes of this Agreement,
“Buyer Material Adverse Effect” means a material adverse effect on the assets,
business, condition (financial or otherwise), results of operations or future
prospects of the Buyer and its subsidiaries, taken as a whole. The Buyer is
not
a shell company as defined in Rule 12b-2 under the Exchange Act.
3.2 Capitalization.
(a) The
authorized and outstanding capital stock of the Buyer (on a fully diluted basis)
is set forth on Section 3.2(a) of the Disclosure Schedule. All of the issued
and
outstanding shares of Buyer Common Stock are duly authorized, validly issued,
fully paid, nonassessable and free of all preemptive rights. Other
than as set forth in the previous sentence and other than securities issuable
pursuant
to the transactions contemplated by this Agreement,
there
are
no outstanding securities, options, warrants, calls, rights, commitments,
agreements, arrangements or undertakings of any kind (contingent or otherwise)
to which Buyer is a party or bound obligating Buyer to issue, deliver or sell,
or cause to be issued, delivered or sold additional shares of capital stock
or
other voting securities of Buyer or obligating Buyer to issue, grant, extend
or
enter into any agreement to issue, deliver or sell any such capital stock or
securities.
(b) Neither
Buyer nor any Subsidiary of Buyer is subject to any obligation or requirement
to
provide material funds for or to make any material investment (in the form
of a
loan or capital contribution) in any Person (other than to or in the Buyer
or
any of its Subsidiaries). There are no accrued or unpaid dividends with respect
to any issued and outstanding shares of any class or series of capital stock
of
Buyer. There are no bonds, debentures, notes or other indebtedness of Buyer
having the right to vote (or convertible into securities having the right to
vote) on any matters on which stockholders of Buyer may vote. Except for
pursuant to the Registration Rights Agreement dated as of October 27, 2006,
no
Person has the right to require Buyer to register any capital stock under the
Securities Act.
(c) All
of
the Merger Shares will be, when issued in accordance with this Agreement, duly
authorized, validly issued, fully paid, nonassessable and free of all preemptive
rights.
(d) The
issuance of the Merger Shares is exempt from the registration requirements
of
the
Securities Act.
3.3 Authorization
of Transaction.
Each of
the Buyer and the Transitory Subsidiary has all requisite power and authority
to
execute and deliver this Agreement and (in the case of the Buyer) the Escrow
Agreement and to perform its obligations hereunder and thereunder. The execution
and delivery by the Buyer and the Transitory Subsidiary of this Agreement and
(in the case of the Buyer) the Escrow Agreement and the consummation by the
Buyer and the Transitory Subsidiary of the transactions contemplated hereby
and
thereby have been duly and validly authorized by all necessary corporate action
on the part of the Buyer and Transitory Subsidiary, respectively. This Agreement
has been duly and validly executed and delivered by the Buyer and the Transitory
Subsidiary and constitutes a valid and binding obligation of the Buyer and
the
Transitory Subsidiary, enforceable against them in accordance with its
terms.
25
3.4 Noncontravention.
Subject
to compliance with the applicable requirements of the Securities Act and any
applicable state securities laws, the Exchange Act and the filing of the
Certificate of Merger as required by the Delaware General Corporation Law,
neither the execution and delivery by the Buyer or the Transitory Subsidiary
of
this Agreement or (in the case of the Buyer) the Escrow Agreement, nor the
consummation by the Buyer or the Transitory Subsidiary of the transactions
contemplated hereby or thereby, will (a) conflict with or violate any
provision of the charter or By-laws of the Buyer or the Transitory Subsidiary,
(b) require on the part of the Buyer or the Transitory Subsidiary any
filing with, or permit, authorization, consent or approval of, any Governmental
Entity, (c) conflict with, result in breach of, constitute (with or without
due notice or lapse of time or both) a default under, result in the acceleration
of obligations under, create in any party any right to terminate, modify or
cancel, or require any notice, consent or waiver under, any contract or
instrument to which the Buyer or the Transitory Subsidiary is a party or by
which either is bound or to which any of their assets are subject, except for
(i) any conflict, breach, default, acceleration, termination, modification
or cancellation which would not adversely affect the consummation of the
transactions contemplated hereby or (ii) any notice, consent or waiver the
absence of which would not adversely affect the consummation of the transactions
contemplated hereby, or (d) violate any order, writ, injunction, decree,
statute, rule or regulation applicable to the Buyer or the Transitory Subsidiary
or any of their properties or assets.
3.5 SEC
Filings.
(a) As
of
their respective filing dates, all of the forms, reports and documents filed
by
Buyer with the U.S. Securities and Exchange Commission (“SEC”) on or after
October 31, 2006 (collectively, the “Buyer SEC Filings”) complied in all
material respects with the requirements of the Securities Act and the Exchange
Act, as the case may be, and none of Buyer SEC Filings contained any untrue
statement of a material fact or omitted to state a material fact required to
be
stated therein or necessary to make the statements made therein, in the light
of
the circumstances under which they were made, not misleading, in each case
except to the extent corrected by a subsequent Buyer SEC Filing. The financial
statements of Buyer included in Buyer SEC Filings complied as to form in all
material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto, were prepared in
accordance with GAAP (except, in the case of unaudited statements, as permitted
by Form 10-Q of the SEC) applied on a consistent basis during the periods
involved (except as may be indicated in the notes thereto) and fairly presented
the consolidated financial position of Buyer as of the dates thereof and the
consolidated results of its operations and cash flows for the periods then
ended
(subject, in the case of unaudited statements, to normal year-end audit
adjustments). Between October 31, 2006 and the date of this Agreement, Buyer
has
not incurred any liabilities of the type required to be disclosed in the
liabilities column of a balance sheet prepared in accordance with GAAP, except
for liabilities incurred in the ordinary course of business.
26
(b) The
management of Buyer has established and maintains disclosure controls and
procedures (as defined in 15d-15(e) of the Exchange Act) to ensure that material
information required to be disclosed by Buyer in the reports that it files
or
submits under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the SEC’s rules and forms and is
accumulated and communicated to Buyer’s management as appropriate to allow
timely decisions regarding required disclosure. Buyer has complied with the
applicable provisions of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and
regulations promulgated thereunder or under the Exchange Act. Each Buyer SEC
Filing that was required to be accompanied by a certification required to be
filed or submitted by the Company’s principal executive officer or the Company’s
principal financial officer was accompanied by such certification and at the
time of filing such certification was, to the knowledge of the Company, true
and
accurate.
3.6 Financial
Statements.
The
audited financial statements and unaudited interim financial statements of
the
Buyer included in the Buyer SEC Filings (i) complied as to form in all
material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto when filed, (ii) were
prepared in accordance with GAAP applied on a consistent basis throughout the
periods covered thereby (except as may be indicated therein or in the notes
thereto), (iii) fairly present the consolidated financial condition,
results of operations and cash flows of the Buyer as of the respective dates
thereof and for the periods referred to therein, and (iv) are consistent
with the books and records of the Buyer.
3.7 Undisclosed
Liabilities.
Buyer
and its Subsidiaries do not have any material liabilities or obligations,
whether fixed, contingent, accrued or otherwise, liquidated or unliquidated
and
whether due or to become due, in each case of a nature required by GAAP to
be
reflected on a consolidated balance sheet of Buyer, other than: (i) liabilities
reflected or reserved against on the balance sheet contained in Buyer’s Form 8-K
filed with the SEC on October 31, 2006; (ii) liabilities or obligations incurred
since October 31, 2006 in the Ordinary Course of Business consistent in all
material respects with past practice; and (iii) liabilities or obligations
that
would not reasonably be expected to have a Buyer Material Adverse
Effect.
3.8 Solvency.
As of
and immediately following the Effective Time, (a) Buyer and the Surviving
Corporation shall be able to pay their respective debts as they become due
and
shall own assets having a fair saleable value greater than the amounts required
to pay their respective debts (including a reasonable estimate of the amount
of
all contingent liabilities) as they become due, and (b) Buyer and the Surviving
Corporation shall have reasonably adequate capital to carry on their respective
businesses. No transfer of property is being made and no obligation is being
incurred in connection with the Merger and the other transactions contemplated
by this Agreement with the intent to hinder, delay or defraud either present
or
future creditors of Buyer or the Surviving Corporation.
3.9 Financing.
At
the
Closing, Buyer and the Transitory Subsidiary will have sufficient funds to
consummate the Merger.
27
3.10 Subsidiaries.
Each of
the Subsidiaries of Buyer is a corporation duly organized, validly existing
and
in corporate and tax good standing under the laws of the jurisdiction of its
incorporation. The Transitory Subsidiary was formed solely to effectuate the
Merger. Buyer has delivered or made available to the Company complete and
accurate copies of the charter, bylaws or other organizational documents of
each
Subsidiary of Buyer. The Transitory Subsidiary has no assets other than minimal
paid-in capital, has no liabilities or other obligations, and is not in default
under or in violation of any provision of its charter, bylaws or other
organizational documents. All of the issued and outstanding shares of capital
stock of the Transitory Subsidiary is duly authorized, validly issued, fully
paid, nonassessable and free of preemptive rights. All shares of the Transitory
Subsidiary is owned by Buyer free and clear of any restrictions on transfer
(other than restrictions under the Securities Act and state securities laws),
claims, security interests, options, warrants, rights, contracts, calls,
commitments, equities and demands. There are no outstanding or authorized
options, warrants, rights, agreements or commitments to which Buyer or the
Transitory Subsidiary is a party or which are binding on any of them providing
for the issuance, disposition or acquisition of any capital stock of any
Subsidiary of Buyer. There are no outstanding stock appreciation, phantom stock
or similar rights with respect to the Transitory Subsidiary. There are no voting
trusts, proxies or other agreements or understandings with respect to the voting
of any capital stock of the Transitory Subsidiary.
3.11 Absence
of Material Adverse Change.
Since
the date of the Buyer SEC Filings, there has occurred no event or development
which has had, or could reasonably be expected to have in the future, a Buyer
Material Adverse Effect.
3.12 Intellectual
Property.
(a) The
Buyer
owns or has the right to use all Intellectual Property necessary (i) to provide
the services provided by the Buyer to other parties (together, the “Buyer
Deliverables”) and (ii) to operate the Internal Systems of the Buyer; the
Intellectual Property owned by or licensed to the Buyer and incorporated in
or
underlying the Buyer Deliverables or the Buyer’s Internal Systems is referred to
herein as the “Buyer Intellectual Property”). Each item of Buyer Intellectual
Property will be owned or available for use by the Surviving Corporation
immediately following the Closing on substantially identical terms and
conditions as it was immediately prior to the Closing. The Buyer has taken
all
reasonable measures to protect the proprietary nature of each item of Buyer
Intellectual Property. To the knowledge o the Buyer, except for the works of
authorship uploaded by the Buyer’s users to the websites hosted by the Buyer or
in the course of services provided by the Buyer and works that may be alleged
to
be infringed by the Buyer on facts analogous to those alleged in the Record
Label Litigation (a) no other person or entity has any rights to any of the
Buyer Intellectual Property owned by the Buyer (except pursuant to agreements
or
licenses specified in Section 3.12(c) of the Disclosure Schedule), and (b)
no
other person or entity is infringing, violating or misappropriating any of
the
Buyer Intellectual Property.
(b) None
of
the Buyer Deliverables, or the marketing, distribution, provision or use thereof
by the Buyer, infringes or violates, or constitutes a misappropriation of,
any
Intellectual Property rights of any person or entity. To the knowledge of the
Buyer, none of the Internal Systems, or the use thereof by the Buyer, infringes
or violates, or constitutes a misappropriation of, any Intellectual Property
rights of any person or entity. Section 3.12(b) of the Disclosure Schedule
lists
any complaint, claim or notice, or written threat thereof, other than made
available in the Buyer SEC Filings, received by the Buyer alleging any such
infringement, violation or misappropriation; and the Buyer has provided or,
through the Buyer SEC Filings, made available to the Company complete and
accurate copies of all written documentation in the possession of the Buyer
or
any Subsidiary relating to any such complaint, claim, notice or threat. The
Buyer has provided or, through the Buyer SEC Filings, made available to the
Company complete and accurate copies of all written documentation in the Buyer’s
possession relating to claims or disputes known to the Buyer concerning any
Buyer Intellectual Property.
28
(c) Section
3.12(c) of the Disclosure Schedule identifies each license or other agreement
(or type of license or other agreement) not made available in the Buyer SEC
Filings pursuant to which the Buyer has licensed, distributed or otherwise
granted any rights to any third party with respect to, any Buyer Intellectual
Property.
(d) Section
3.12(d) of the Disclosure Schedule identifies each item of Buyer Intellectual
Property not made available in the Buyer SEC Filings that is owned by a party
other than the Buyer, and the license or agreement pursuant to which the Buyer
uses it (excluding off the shelf software programs licensed by the Buyer
pursuant to “shrink wrap” licenses).
(e) The
Buyer
has not disclosed the source code for any of the software owned by the Buyer
(the “Buyer Software”) or other confidential information constituting, embodied
in or pertaining to the Buyer Software to any person or entity, except pursuant
to the agreements listed in Section 3.12(e) of the Disclosure Schedule or made
available in the Buyer SEC Filings, and the Buyer has taken reasonable measure
to prevent disclosure of such source code.
(f) All
of
the copyrightable materials (including Buyer Software) except for Buyer Provided
Content (works of authorship uploaded by Buyer’s customers in the course of
using the services provided by Buyer) incorporated in or bundled with the Buyer
Deliverables have been created by employees of the Buyer within the scope of
their employment by the Buyer or by independent contractors of the Buyer who
have executed agreements expressly assigning all right, title and interest
in
such copyrightable materials to the Buyer. No portion of such copyrightable
materials was jointly developed with any third party.
(g) To
the
knowledge of the Buyer, the Buyer Deliverables and the Internal Systems are
free
from significant defects or programming errors and conform in all material
respects to the written documentation and specifications therefor.
3.13 Litigation.
Except
as disclosed in the Buyer SEC Filings, as of the date of this Agreement, there
is no Legal Proceeding which is pending or, to the Buyer’s knowledge, threatened
against the Buyer or any subsidiary of the Buyer which, if determined adversely
to the Buyer or such subsidiary, could have, individually or in the aggregate,
a
Buyer Material Adverse Effect or which in any manner challenges or seeks to
prevent, enjoin, alter or delay the transactions contemplated by this
Agreement.
29
3.14 Interim
Operations of the Transitory Subsidiary.
The
Transitory Subsidiary was formed solely for the purpose of engaging in the
transactions contemplated by this Agreement and has engaged in no business
activities other than as contemplated by this Agreement.
3.15 Brokers’
Fees.
Neither
the Buyer nor the Transitory Subsidiary has any liability or obligation to
pay
any fees or commissions to any broker, finder or agent with respect to the
transactions contemplated by this Agreement.
3.16 No
Buyer Vote Required.
No vote
or other action of the stockholders of Buyer is required by the laws of the
state of Nevada, the organizational documents of Buyer or otherwise in order
for
Buyer to consummate the transactions contemplated by this
Agreement.
3.17 Disclosure.
No
representation or warranty by the Buyer contained in this Agreement, and no
statement contained in the any document, certificate or other instrument
delivered or to be delivered by or on behalf of the Buyer pursuant to this
Agreement, contains or will contain any untrue statement of a material fact
or
omits or will omit to state any material fact necessary, in light of the
circumstances under which it was or will be made, in order to make the
statements herein or therein not misleading.
ARTICLE
IV
COVENANTS
4.1 Closing
Efforts; Company Financial Statements.
(a) Each
of
the Parties shall use its best efforts, to the extent commercially reasonable
(“Reasonable Best Efforts”), to take all actions and to do all things necessary,
proper or advisable to consummate the transactions contemplated by this
Agreement, including without limitation using its Reasonable Best Efforts to
ensure that (i) its representations and warranties remain true and correct
in all material respects through the Closing Date, (ii) the conditions to
the obligations of the other Parties to consummate the Merger are satisfied,
(iii) the Buyer’s preparation of consolidated pro forma financial
statements by the Buyer’s independent accountants, the Buyer, the Company and
the Subsidiaries are prepared in an accurate, complete and timely fashion and
in
accordance with GAAP, including without limitation the assistance of Company’s
management and employees with regard to providing records, information and
all
other assistance requested by Buyer in a responsive manner so as to facilitate
the expeditions preparation of such financial statements and (iv) the Merger
qualifies as a “plan of reorganization” under Section 368(a) of the Code
(including making any amendments to this Agreement as may be advisable in the
view of tax counsel to Buyer and the Company).
(b) The
Company shall use its Reasonable Best Efforts to assist Buyer and auditors
selected by the Buyer in the preparation and delivery to the Buyer the following
(1) the unaudited consolidated balance sheet and statements of income, changes
in stockholders’ equity and cash flows as of and for the twelve months ended as
of December 31, 2006 and (2) a reconciliation statement with respect to the
Company’s Financial Statements and the December 31, 2006 financial statements
referred to the in the foregoing clause (1) identifying in reasonable detail
all
material differences between the manner as presented and the manner as if
presented in accordance with GAAP. The Company shall also use its Reasonable
Best Efforts to assist Buyer and auditors selected by the Buyer in the conduct
of an audit of the financial statements of the Company for prior periods, with
a
view towards preparing combined, consolidated audited financial statements
of
Buyer and the Company on a pro forma basis. Fees payable to third parties by
the
Company or the Buyer for audit services and other professional services
performed in connection with the preparation of financial statements and
reconciliation pursuant to this Section 4.1(b)
shall be
at the Buyer’s sole expense.
30
(c) Notwithstanding
the foregoing or any other thing in this Agreement to the contrary, Buyer shall
have the right to terminate this Agreement and the transactions contemplated
hereby in its sole discretion if a settlement agreement upon terms and
conditions reasonably satisfactory to the Buyer of the litigation pending in
the
United States District Court for the Central District of California, entitled
UMG
Recordings, Inc.,
et
al
v. Bolt, Inc.,
et
al,
CV
06-06577 has not been entered into and delivered by UMG Recordings, Inc. and
the
Company on or before the date that is five (5) days from the date of this
Agreement.
4.2 Governmental
and Third-Party Notices and Consents.
(a) Each
Party shall use its Reasonable Best Efforts to obtain, at its expense, all
waivers, permits, consents, approvals or other authorizations from Governmental
Entities, and to effect all registrations, filings and notices with or to
Governmental Entities, as may be required for such Party to consummate the
transactions contemplated by this Agreement and to otherwise comply with all
applicable laws and regulations in connection with the consummation of the
transactions contemplated by this Agreement.
(b) The
Company shall use its Reasonable Best Efforts to obtain, at its expense, all
such waivers, consents or approvals from third parties, and to give all such
notices to third parties, as are required to be listed in Section 2.4 of
the Disclosure Schedule.
4.3 Stockholder
Approval.
(a) The
Company shall use its Reasonable Best Efforts to obtain, as promptly as
practicable, the Requisite Stockholder Approval, either at a special meeting
of
stockholders or pursuant to a written stockholder consent, all in accordance
with the applicable requirements of the Delaware General Corporation Law. In
connection with such special meeting of stockholders or written stockholder
consent, the Company shall provide to its stockholders a written proxy or
information statement (the “Disclosure Statement”) which includes (A) a summary
of the Merger and this Agreement (which summary shall include a summary of
the
terms relating to the indemnification obligations of the Company Stockholders,
the escrow arrangements and the authority of the Indemnification Representative,
and a statement that the adoption of this Agreement by the stockholders of
the
Company shall constitute approval of such terms), (B) all of the information
required by Rule 502(b)(2) of Regulation D under the Securities Act and
(C) a statement that appraisal rights are available for the Company Shares
pursuant to Section 262 of the Delaware General Corporation Law and a copy
of such Section 262. The Buyer agrees to cooperate with the Company in the
preparation of the Disclosure Statement. The Company agrees not to distribute
the Disclosure Statement until the Buyer has had a reasonable opportunity to
review and comment on the Disclosure Statement and the Disclosure Statement
has
been approved by the Buyer (which approval may not be unreasonably withheld
or
delayed). If the Requisite Stockholder Approval is obtained by means of a
written consent, the Company shall send, pursuant to Sections 228 and
262(d) of the Delaware General Corporation Law, a written notice to all
stockholders of the Company that did not execute such written consent informing
them that this Agreement and the Merger were adopted and approved by the
stockholders of the Company and that appraisal rights are available for their
Company Shares pursuant to Section 262 of the Delaware General Corporation
Law (which notice shall include a copy of such Section 262), and shall
promptly inform the Buyer of the date on which such notice was
sent.
31
(b) The
Company, acting through its Board of Directors, shall include in the Disclosure
Statement the unanimous recommendation of its Board of Directors that the
stockholders of the Company vote in favor of the adoption of this Agreement
and
the approval of the Merger. Notwithstanding the foregoing, the obligation set
forth in the foregoing sentence shall not apply (and the Board of Directors
shall be permitted to modify or withdraw any such recommendation previously
made) if:
(i) the
Company receives an unsolicited bona fide written offer to acquire (whether
by
way of merger, consolidation, share exchange, stock purchase or asset purchase)
all of the outstanding capital stock or all or substantially all of the assets
of the Company, which satisfies each of the following conditions (such an offer
being referred to herein as a “Superior Offer”): (A) such offer is subject
only to customary conditions (which may include the termination of this
Agreement, but which may not include any financing condition), (B) the
Board of Directors of the Company reasonably concludes, after consultation
with
its outside legal counsel and its financial advisors, that such offer would
likely be consummated if the Company were to accept it, and (C) the Board
of Directors of the Company reasonably concludes, after consultation with its
financial advisors, that such offer would, if consummated, constitute a
transaction which is more favorable, from a financial point of view, to the
stockholders of the Company than the Merger; and
(ii) the
Board
of Directors of the Company reasonably concludes, after consultation with its
outside legal counsel, that the fiduciary duties of the Board of Directors
under
applicable law permit it to accept the Superior Offer, provided that such
conclusion shall be supported by and consistent with a comparative valuation
report prepared by the Company’s financial advisor and presented to the
Company’s Board of Directors prior to the determination of whether to accept a
Superior Offer, which report shall set forth such financial advisor’s evaluation
of the Superior Offer versus the transaction contemplated by this
Agreement.
(c) The
Company shall ensure that the Disclosure Statement does not contain any untrue
statement of a material fact or omit to state a material fact necessary in
order
to make the statements made, in light of the circumstances under which they
were
made, not misleading (provided that the Company shall not be responsible for
the
accuracy or completeness of any information furnished by the Buyer in writing
for inclusion in the Disclosure Statement).
32
(d) The
Buyer
shall ensure that any information furnished by the Buyer to the Company in
writing for inclusion in the Disclosure Statement does not contain any untrue
statement of a material fact or omit to state a material fact necessary in
order
to make the statements made, in light of the circumstances under which they
were
made, not misleading.
4.4 Operation
of Business.
Except
as contemplated by this Agreement, during the period from the date of this
Agreement to the Effective Time, the Company shall (and shall cause each
Subsidiary to) conduct its operations in the Ordinary Course of Business and
in
compliance with all applicable laws and regulations and, to the extent
consistent therewith, use its Reasonable Best Efforts to preserve intact its
current business organization, keep its physical assets in good working
condition, keep available the services of its current officers and employees
and
preserve its relationships with customers, suppliers and others having business
dealings with it to the end that its goodwill and ongoing business shall not
be
impaired in any material respect. Without limiting the generality of the
foregoing, prior to the Effective Time, the Company shall not (and shall cause
each Subsidiary not to), without the written consent of the Buyer:
(a) issue
or
sell, or redeem or repurchase, any stock or other securities of the Company
or
any rights, warrants or options to acquire any such stock or other securities
(except pursuant to the conversion or exercise of convertible securities or
Options or Warrants outstanding on the date hereof), or amend any of the terms
of (including without limitation the vesting of) any such convertible securities
or Options or Warrants;
(b) split,
combine or reclassify any shares of its capital stock; declare, set aside or
pay
any dividend or other distribution (whether in cash, stock or property or any
combination thereof) in respect of its capital stock;
(c) create,
incur or assume any indebtedness (including obligations in respect of capital
leases but not including trade payables incurred in the Ordinary Course of
Business); assume, guarantee, endorse or otherwise become liable or responsible
(whether directly, contingently or otherwise) for the obligations of any other
person or entity; or make any loans, advances or capital contributions to,
or
investments in, any other person or entity;
(d) enter
into, adopt or amend any Employee Benefit Plan or any employment or severance
agreement or arrangement or increase in any manner the compensation or fringe
benefits of, or materially modify the employment terms of, its directors,
officers or employees, generally or individually, or pay any bonus or other
benefit to its directors, officers or employees, except for (1) amendments
to an
Employee Benefit Plan listed on Section 2.21(b) of the Disclosure Schedule
which
are required by law, (2) normal compensation increases in the ordinary course
of
business and (3) existing payment obligations listed in Section 2.20 of the
Disclosure Schedule;
(e) acquire,
sell, lease, license or dispose of any assets or property (including without
limitation any shares or other equity interests in or securities of any
Subsidiary or any corporation, partnership, association or other business
organization or division thereof), other than acquisitions, sales, leases,
licenses and dispositions of assets or property in the Ordinary Course of
Business;
33
(f) mortgage
or pledge any of its property or assets or subject any such property or assets
to any Security Interest;
(g) discharge
or satisfy any Security Interest or pay any obligation or liability other than
in the Ordinary Course of Business;
(h) amend
its
charter, by-laws or other organizational documents;
(i) change
in
any material respect its accounting methods, principles or practices, except
insofar as may be required by a generally applicable change in
GAAP;
(j) enter
into, amend, terminate, take or omit to take any action that would constitute
a
violation of or default under, or waive any rights under, any material contract
or agreement;
(k) make
or
commit to make any capital expenditure in excess of $50,000 per item or $100,000
in the aggregate;
(l) institute
or settle any Legal Proceeding including without limitation making any offers
of
settlement thereof, including offers of settlement to Sony, BMG Entertainment,
Warner Music Group, Universal Music Group, and EMI Recorded Music (each a “Major
Record Label” and collectively the Major Record Labels”) and any independent
record label, in each case in connection with the Record Label Litigation,
it
being acknowledged and agreed that any settlement offer(s) or agreement(s)
regarding the Record Label Litigation shall only be made with the prior approval
of the Buyer;
(m) take
any
action or fail to take any action permitted by this Agreement with the knowledge
that such action or failure to take action would result in (i) any of the
representations and warranties of the Company set forth in this Agreement
becoming untrue or (ii) any of the conditions to the Merger set forth in
Article V not being satisfied; or
(n) agree
in
writing or otherwise to take any of the foregoing actions.
4.5 Access
to Information.
(a) The
Company shall (and shall cause each Subsidiary to) permit representatives of
the
Buyer to have full access (at all reasonable times, and in a manner so as not
to
interfere with the normal business operations of the Company and the
Subsidiaries) to all premises, properties, financial and accounting records,
contracts, other records and documents, and personnel, of or pertaining to
the
Company and each Subsidiary.
(b) Prior
to
or on the date of this Agreement (with respect to the month ended
December 31, 2006) and within 15 days after the end of each month ending
prior to the Closing, beginning with February 15, 2007 (with respect to the
month ended January 31, 2007), the Company shall furnish to the Buyer an
unaudited income statement for such month and a balance sheet as of the end
of
such month, prepared on a basis consistent with the Financial Statements. Such
financial statements shall present fairly the financial condition and results
of
operations of the Company and the Subsidiaries on a consolidated basis as of
the
dates thereof and for the periods covered thereby, and shall be consistent
with
the books and records of the Company and the Subsidiaries.
34
(c) Each
of
the Buyer and the Transitory Subsidiary (i) shall treat and hold as
confidential any Confidential Information (as defined below), (ii) shall
not use any of the Confidential Information except in connection with this
Agreement, and (iii) if this Agreement is terminated for any reason
whatsoever, shall return to the Company all tangible embodiments (and all
copies) thereof which are in its possession. For purposes of this Agreement,
“Confidential Information” means any confidential or proprietary information of
the Company or any Subsidiary that is furnished in writing to the Buyer or
the
Transitory Subsidiary by the Company or any Subsidiary in connection with this
Agreement and is labeled confidential or proprietary; provided,
however,
that it
shall not include any information (A) which, at the time of disclosure, is
available publicly, (B) which, after disclosure, becomes available publicly
through no fault of the Buyer or the Transitory Subsidiary, (C) which the
Buyer or the Transitory Subsidiary knew or to which the Buyer or the Transitory
Subsidiary had access prior to disclosure or (D) which the Buyer or the
Transitory Subsidiary rightfully obtains from a source other than the Company
or
a Subsidiary.
4.6 Exclusivity.
(a) The
Company shall not, and the Company shall require each of its officers,
directors, employees, representatives and agents not to, directly or indirectly,
(i) initiate, solicit, encourage or otherwise facilitate any inquiry,
proposal, offer or discussion with any party (other than the Buyer) concerning
any merger, reorganization, consolidation, recapitalization, business
combination, liquidation, dissolution, share exchange, sale of stock, sale
of
material assets or similar business transaction involving the Company, any
Subsidiary or any division of the Company, (ii) furnish any non-public
information concerning the business, properties or assets of the Company, any
Subsidiary or any division of the Company to any party (other than the Buyer)
or
(iii) engage in discussions or negotiations with any party (other than the
Buyer) concerning any such transaction. Notwithstanding the foregoing, prior
to
the obtaining of the Requisite Stockholder Approval, the Company may furnish
non-public information concerning the business, properties or assets of the
Company, a Subsidiary or a division of the Company to another party, and may
engage in discussions or negotiations with such party, if (x) the Company
receives a Superior Offer from such party, (y) the Company first executes
with such party a confidentiality agreement with terms no less favorable to
the
Company than those contained in the Confidentiality Agreement between the Buyer
and the Company dated December 1, 2006 and (z) the Board of Directors of
the Company reasonably concludes, after consultation with its outside legal
counsel, that the fiduciary duties of the Board of Directors under applicable
law permit the Company to do so.
(b) The
Company shall immediately notify any party with which discussions or
negotiations of the nature described in paragraph (a) above were pending
that the Company is terminating such discussions or negotiations. If the Company
receives any inquiry, proposal or offer of the nature described in
paragraph (a) above, the Company shall, within one business day after such
receipt, notify the Buyer of such inquiry, proposal or offer, including the
identity of the other party and the terms of such inquiry, proposal or offer.
If
the Company makes a determination under the final sentence of paragraph (a)
above that it is permitted to furnish non-public information and/or engage
in
discussions or negotiations with another party, the Company shall, within one
business day after such determination, notify the Buyer in writing of such
determination and the basis therefor, and shall keep the Buyer informed, on
a
current basis, of the status of such discussions or negotiations and the terms
being discussed or negotiated.
35
4.7 Expenses.
Except
as set forth in Article VI and the Escrow Agreement, each of the Parties
shall bear its own costs and expenses (including legal fees and expenses and
the
fees and expenses of each Party’s own financial advisors and investment bankers)
incurred in connection with this Agreement and the transactions contemplated
hereby (the “Transaction Expenses”). Notwithstanding the foregoing, prior to the
Closing, the Company will provide to Buyer an itemized and complete list (the
“Transaction Expenses List”) of all Transaction Expenses incurred or to be
incurred by the Company prior to or in connection with the Closing. Any of
the
Company’s Transaction Expenses that were not paid by the Company prior to the
Closing shall be paid by the Buyer or the Surviving Corporation to the extent
that such Transaction Expenses do not exceed $250,000. In the event that the
Company’s Transaction Expenses that were not paid by the Company prior to the
Closing exceed $250,000 (such expenses, “Excess Transaction Expenses”), then
such Excess Transaction Expenses shall be paid by Buyer or the Surviving
Corporation and Buyer shall have the right to be reimbursed by the Escrow Agent
from the Escrow Fund on a dollar-for-dollar basis. In addition, notwithstanding
anything herein to the contrary, Buyer shall not be responsible for (i) any
fees, costs, expenses or other obligations or liabilities of the Major
Stockholders, the Management Shareholders or any other of the Company
Stockholders or (ii) any fees, costs, expenses or other obligations or
liabilities of the Company incurred in connection with the Merger except those
that are solely and directly related to the Merger within the meaning of Revenue
Ruling 73-54. Schedule 4.7 sets forth the Company’s good faith estimate of the
Transaction Expenses by vendor, category and amount. Notwithstanding any other
provision of this Agreement, the fees and expenses of counsel with respect
to
the Record Label Litigation shall be deemed to be Transaction Expenses. At
the
Closing, the Buyer shall issue to Savvian, LLC a number of shares of Buyer
Common Stock equal to $750,000 divided by (y) the Average Pre-Signing Price
and
shall issue additional shares of Buyer Common Stock to Savvian, LLC in
accordance with Schedule 1.5(a)(v).
4.8 Directors
and Officers Insurance; Indemnification.
(a) Buyer
shall purchase, to the extent commercially available at a cost per annum to
the
Buyer of not greater than $50,000, “prior acts” coverage, for a term of not less
than six (6) years, for the benefit of present and former officers and directors
of the Company in respect to any claim asserted against such officers and
directors, or any of them, arising from acts or omissions in their capacity
as
officers and/or directors of the Company occurring prior to the Effective
Time.
(b) Until
the
sixth (6th)
anniversary of the Closing Date, the Certificate of Incorporation and Bylaws
of
the Surviving Corporation shall contain, and Buyer shall cause the Certificate
of Incorporation and Bylaws of the Surviving Corporation to so contain,
provisions no less favorable with respect to indemnification, advancement of
expenses and exculpation of present and former directors and officers of the
Company and its Subsidiaries than are presently set forth in the Certificate
of
Incorporation and Bylaws of the Buyer.
36
(c) The
provisions of this Section 4.8 are intended to be in addition to the rights
otherwise available to the current officers and directors of the Company by
law,
charter, bylaw or agreement, and shall operate for the benefit of, and shall
be
enforceable by, each of the Indemnified Directors and Officers, or, if such
person has died, his or her estate.
4.9 Listing
of Merger Shares.
Buyer
shall take whatever steps are necessary to cause the Merger Shares to be
eligible for quotation on the OTCBB.
4.10 Securities
Filings.
Buyer
shall make, within the specified time periods, all required filings with respect
to the Merger Shares with the SEC and state securities agencies including,
without limitation, filing of Form D with the SEC.
4.11 Employee
Benefits Obligation of Buyer.
For
purposes of determining eligibility, vesting and benefit accruals under the
employee benefit plans of Buyer or the Surviving Corporation to individuals
employed by the Company Immediately prior to the Closing Date who continue
their
employment with the Surviving Corporation or any of its subsidiaries on and
after the Closing Date (each, a “Continuing Employee” and such employee benefit
plans, the “Buyer Benefit Plans”), Buyer shall credit, or cause to be credited,
each Continuing Employee with his or her years of service with the Company,
its
Subsidiaries that are ERISA Affiliates, and any predecessor entities, to the
same extent as such Continuing Employee was entitled to credit for such service
under any Employee Benefit Plan maintained immediately prior to the Closing
Date
by the Company or any ERISA Affiliate, except that Continuing Employees shall
receive no such credit (i) to the extent that such credit would result in a
duplication of benefits or (ii) under any newly-established Buyer Benefit Plan
for which similarly-situated employees of Buyer do not receive credited service.
The Buyer Benefit Plans that are “group health plans” (within the meaning of
Section 5000(b)(1) of the Code), shall not deny Continuing Employees coverage
under the Buyer Benefit Plans that are “group health plans” (within the meaning
of Section 5000(b)(1) of the Code) on the basis of pre-existing conditions
and
shall credit such Continuing Employees (and their dependents) for any
deductibles and out-of-pocket expenses paid under the Employee Benefit Plans
maintained by the Company or any ERISA Affiliate in the year of initial
participation in the applicable Buyer Benefit Plans that are group health plans
(within the meaning of Section 5000(b)(1) of the Code). The Buyer shall satisfy
or cause to be satisfied and be fully responsible for any and all COBRA
obligations that arise with respect to any “M&A Beneficiary” (as such term
is defined in as defined in Treasury Regulation Section 54.4980B-9, Q&A
4).
4.12 Preparation
of Securities Disclosures.
If
prior to the Closing Date the Buyer determines to prepare or distribute any
offering materials including disclosures pertaining to the Company then the
Buyer shall involve the Company to the extent it deems necessary to prepare
such
materials and shall keep the Company reasonably informed regarding the status
or
progress of any such transaction, and the Company shall provide all reasonable
assistance related thereto to the Buyer and its accountants, auditors,
attorneys, financial advisors and/or other professional service providers of
the
Buyer.
37
ARTICLE
V
CONDITIONS
TO CONSUMMATION OF MERGER
5.1 Conditions
to Each Party’s Obligations.
The
respective obligations of each Party to consummate the Merger are subject to
the
satisfaction, on or prior to the Termination Date, of the following
condition:
(a) this
Agreement and the Merger shall have received the Requisite Stockholder
Approval.
5.2 Conditions
to Obligations of the Buyer and the Transitory Subsidiary.
The
obligation of each of the Buyer and the Transitory Subsidiary to consummate
the
Merger is subject to the satisfaction (or waiver by the Buyer), on or prior
to
the Termination Date, of the following additional conditions:
(a) the
number of Dissenting Shares shall not exceed 10% of the number of outstanding
Common Shares as of the Effective Time (calculated after giving effect to the
conversion into Common Shares of all outstanding Preferred Shares);
(b) the
Company and the Subsidiaries shall have obtained (and shall have provided copies
thereof to the Buyer) all of the waivers, permits, consents, approvals or other
authorizations, and effected all of the registrations, filings and notices,
referred to in Section 4.2 which are required on the part of the Company or
the Subsidiaries, except for any the failure of which to obtain or effect would
not, individually or in the aggregate, have a Company Material Adverse Effect
or
a material adverse effect on the ability of the Parties to consummate the
transactions contemplated by this Agreement;
(c) the
representations and warranties of the Company shall have been true and correct
as of the date of the Agreement and shall be true and correct as of the Closing
Date, except with respect to representations and warranties made as of a
particular date which shall be true and correct on and as of such date, except,
in each case, where the failure to be so true and correct has not had and would
not reasonably be expected to, individually or collectively, have a Company
Material Adverse Effect, provided that for purposes of the foregoing, neither
(1) the existence of any conflict, breach, default, acceleration or right in
contravention of Section 2.4(c) that does not itself constitute a Company
Material Adverse Effect nor (2) the existence of or facts underlying the Record
Label Litigation or the Zeocast Litigation shall not be construed as a Company
Material Adverse Effect for purposes of this Section 5.2(c);
(d) the
Company shall have performed or complied with its agreements and covenants
required to be performed or complied with under this Agreement as of or prior
to
the Effective Time, except where the failure to comply has not had and would
not
reasonably be expected to have a Company Material Adverse Effect;
(e) no
Legal
Proceeding shall be pending or threatened wherein an unfavorable judgment,
order, decree, stipulation or injunction would (i) prevent consummation of
any of the transactions contemplated by this Agreement, (ii) cause the
Merger to be rescinded following consummation or (iii) have, individually
or in the aggregate, a Company Material Adverse Effect, provided that for
purposes of this Section 5.2(e), neither (1) the existence of or facts
underlying the Record Label Litigation nor (2) the Zeocast Litigation shall
be
construed as a Company Material Adverse Effect, and no such judgment, order,
decree, stipulation or injunction shall be in effect;
38
(f) the
Company shall have delivered to the Buyer and the Transitory Subsidiary a
certificate (the “Company Certificate”) to the effect that each of the
conditions specified in clause (a) of Section 5.1 and clauses (a)
through (e) (insofar as clause (e) relates to Legal Proceedings involving
the Company or a Subsidiary) of this Section 5.2 is satisfied in all
material respects;
(g) each
of
the Company Stockholders (other than holders of Dissenting Shares) shall have
executed and delivered to the Buyer a counterpart of the Lockup
Agreement;
(h) the
Buyer
shall have received from counsel to the Company an opinion with respect to
the
matters set forth in Exhibit F
attached
hereto, in a form to be reasonably agreed by the Buyer and counsel to the
Company, addressed to the Buyer and dated as of the Closing Date;
(i) the
Buyer
shall have received such other certificates and instruments (including without
limitation certificates of good standing of the Company and the Subsidiaries
in
their jurisdiction of organization and the various foreign jurisdictions in
which they are qualified, certified charter documents, certificates as to the
incumbency of officers and the adoption of authorizing resolutions) as it shall
reasonably request in connection with the Closing; and
(j) the
Buyer, the Surviving Corporation and each of the Managing Shareholders shall
have entered into employment agreements containing non-disclosure, non-compete
obligations, and assignment of invention agreements reasonably acceptable to
the
Buyer and such individuals.
(k) the
Company and each Company Stockholder shall have entered into an agreement in
form and substance reasonably satisfactory to the Buyer providing for an
acknowledgment by each Company Stockholder of the amount of shares held by
it,
an acknowledgment as to the Merger and the Merger Shares to be issuable to
such
Company Stockholder hereunder and a release of the Company and its Subsidiaries
and affiliates for any and all causes of action accrued prior to the effective
time.
5.3 Conditions
to Obligations of the Company.
The
obligation of the Company to consummate the Merger is subject to the
satisfaction on or prior to the Termination Date, of the following additional
conditions:
(a) the
Merger Shares shall have been authorized for quotation on the OTCBB upon
official notice of issuance;
(b) the
Buyer
shall have effected all of the registrations, filings and notices referred
to in
Section 4.2 which are required on the part of the Buyer , except for any
which if not obtained or effected would not have a Buyer Material Adverse Effect
or a material adverse effect on the ability of the Parties to consummate the
transactions contemplated by this Agreement;
(c) the
representations and warranties of the Buyer and the Transitory Subsidiary set
forth in the first sentence of Section 3.1 and Section 3.3 and any
representations and warranties of the Buyer and the Transitory Subsidiary set
forth in this Agreement that are qualified as to materiality shall be true
and
correct, and the representations and warranties of the Buyer and the Transitory
Subsidiary set forth in this Agreement that are not so qualified (other than
those set forth in Section 3.1 and Section 3.3) shall be true and
correct in all material respects, in each case as of the date of this Agreement
and as of the Effective Time as though made as of the Effective Time, except
to
the extent such representations and warranties are specifically made as of
a
particular date (in which case such representations and warranties shall be
true
and correct as of such date);
39
(d) each
of
the Buyer and the Transitory Subsidiary shall have performed or complied with
in
all material respects its agreements and covenants required to be performed
or
complied with under this Agreement as of or prior to the Effective
Time;
(e) no
Legal
Proceeding shall be pending or threatened (other than with respect to the Record
Label Litigation or the Zeocast Litigation) wherein an unfavorable judgment,
order, decree, stipulation or injunction would (i) prevent consummation of
any of the transactions contemplated by this Agreement, (ii) cause any of
the transactions contemplated by this Agreement to be rescinded following
consummation or (iii) have, individually or in the aggregate, a Buyer
Material Adverse Effect, and no such judgment, order, decree, stipulation or
injunction shall be in effect;
(f) the
Buyer
shall have delivered to the Company a certificate (the “Buyer Certificate”) to
the effect that each of the conditions specified in clauses (a) through (e)
(insofar as clause (e) relates to Legal Proceedings involving the Buyer) of
this Section 5.3 is satisfied in all respects;
(g) the
Buyer
shall have executed and delivered to the Company and the Company Stockholders
a
Registration Rights Agreement in the form of Exhibit
G;
(h) the
Company shall have received from counsel to the Buyer and the Transitory
Subsidiary an opinion with respect to the matters set forth in Exhibit H
attached
hereto, in a form to be reasonably agreed by the Company and counsel to the
Buyer, addressed to the Company and dated as of the Closing Date;
and
(i) the
Company shall have received such other certificates and instruments (including
without limitation certificates of good standing of the Buyer and the Transitory
Subsidiary in their jurisdiction of organization, certified charter documents,
certificates as to the incumbency of officers and the adoption of authorizing
resolutions) as it shall reasonably request in connection with the
Closing.
ARTICLE
VI
INDEMNIFICATION
6.1 Indemnification
by the Company Stockholders.
The
holders of Company Shares immediately prior to the Effective Time (the
“Indemnifying Stockholders”) shall indemnify the Buyer in respect of, and hold
it harmless against, any and all debts, obligations and other liabilities
(whether absolute, accrued, contingent, fixed or otherwise, or whether known
or
unknown, or due or to become due or otherwise), monetary damages, fines, fees,
penalties, interest obligations, deficiencies, losses and expenses (including
without limitation amounts paid in settlement, interest, court costs, costs
of
investigators, fees and expenses of attorneys, accountants, financial advisors
and other experts, and other expenses of litigation) (“Damages”) incurred or
suffered by the Surviving Corporation or the Buyer or any Affiliate thereof
resulting from, relating to or constituting:
40
(a) any
misrepresentation, breach of warranty or failure to perform any covenant or
agreement of the Company contained in this Agreement or the Company
Certificate;
(b) any
failure of any Company Stockholder to have good, valid and marketable title
to
the issued and outstanding Company Shares issued in the name of such Company
Stockholder, free and clear of all Security Interests; or
(c) any
claim
by a stockholder or former stockholder of the Company, or any other person
or
entity, seeking to assert, or based upon: (i) ownership or rights to
ownership of any shares of stock of the Company; (ii) any rights of a
stockholder (other than the right to receive the Merger Shares pursuant to
this
Agreement or appraisal rights under the applicable provisions of the Delaware
General Corporation Law), including any option, preemptive rights or rights
to
notice or to vote; (iii) any rights under the Certificate of Incorporation
or By-laws of the Company; or (iv) any claim that his, her or its shares
were wrongfully repurchased by the Company.
6.2 Indemnification
by the Buyer.
The
Buyer shall indemnify the Indemnifying Stockholders in respect of, and hold
them
harmless against, any and all Damages incurred or suffered by the Indemnifying
Stockholders resulting from, relating to or constituting any misrepresentation,
breach of warranty or failure to perform any covenant or agreement of the Buyer
or the Transitory Subsidiary contained in this Agreement or the Buyer
Certificate.
6.3 Indemnification
Claims.
(a) A
party
entitled, or seeking to assert rights, to indemnification under this
Article VI (an “Indemnified Party”) shall give written notification to the
party from whom indemnification is sought (an “Indemnifying Party”) of the
commencement of any suit or proceeding relating to a third party claim for
which
indemnification pursuant to this Article VI may be sought. Such
notification shall be given within 20 business days after receipt by the
Indemnified Party of notice of such suit or proceeding, and shall describe
in
reasonable detail (to the extent known by the Indemnified Party) the facts
constituting the basis for such suit or proceeding and the amount of the claimed
damages; provided, however, that no delay on the part of the Indemnified Party
in notifying the Indemnifying Party shall relieve the Indemnifying Party of
any
liability or obligation hereunder except to the extent of any damage or
liability caused by or arising out of such failure. Within 20 days after
delivery of such notification, the Indemnifying Party may, upon written notice
thereof to the Indemnified Party, assume control of the defense of such suit
or
proceeding with counsel reasonably satisfactory to the Indemnified Party;
provided that (i) the Indemnifying Party may only assume control of such
defense if (A) it acknowledges in writing to the Indemnified Party that any
damages, fines, costs or other liabilities that may be assessed against the
Indemnified Party in connection with such suit or proceeding constitute Damages
for which the Indemnified Party shall be indemnified pursuant to this
Article VI and (B) the ad
damnum
is less
than or equal to the amount of Damages for which the Indemnifying Party is
liable under this Article VI and (ii) the Indemnifying Party may not assume
control of the defense of a suit or proceeding involving criminal liability
or
in which equitable relief is sought against the Indemnified Party. If the
Indemnifying Party does not so assume control of such defense, the Indemnified
Party shall control such defense. The party not controlling such defense (the
“Non-controlling Party”) may participate therein at its own expense; provided
that if the Indemnifying Party assumes control of such defense and the
Indemnified Party reasonably concludes that the Indemnifying Party and the
Indemnified Party have conflicting interests or different defenses available
with respect to such suit or proceeding, the reasonable fees and expenses of
counsel to the Indemnified Party shall be considered Damages for purposes of
this Agreement. The party controlling such defense (the “Controlling Party”)
shall keep the Non-controlling Party advised of the status of such suit or
proceeding and the defense thereof and shall consider in good faith
recommendations made by the Non-controlling Party with respect thereto. The
Non-controlling Party shall furnish the Controlling Party with such information
as it may have with respect to such suit or proceeding (including copies of
any
summons, complaint or other pleading which may have been served on such party
and any written claim, demand, invoice, billing or other document evidencing
or
asserting the same) and shall otherwise cooperate with and assist the
Controlling Party in the defense of such suit or proceeding. The Indemnifying
Party shall not agree to any settlement of, or the entry of any judgment arising
from, any such suit or proceeding without the prior written consent of the
Indemnified Party, which shall not be unreasonably withheld or delayed; provided
that the consent of the Indemnified Party shall not be required if the
Indemnifying Party agrees in writing to pay any amounts payable pursuant to
such
settlement or judgment and such settlement or judgment includes a complete
release of the Indemnified Party from further liability and has no other adverse
effect on the Indemnified Party. The Indemnified Party shall not agree to any
settlement of, or the entry of any judgment arising from, any such suit or
proceeding without the prior written consent of the Indemnifying Party, which
shall not be unreasonably withheld or delayed.
41
(b) In
order
to seek indemnification under this Article VI, an Indemnified Party shall
give written notification (a “Claim Notice”) to the Indemnifying Party which
contains (i) a description and the amount (the “Claimed Amount”) of any Damages
incurred or reasonably expected to be incurred by the Indemnified Party, (ii)
a
statement that the Indemnified Party is entitled to indemnification under this
Article VI for such Damages and a reasonable explanation of the basis
therefor, and (iii) a demand for payment (in the manner provided in
paragraph (c) below) in the amount of such Damages. If the Indemnified
Party is the Buyer, the Indemnifying Party shall deliver a copy of the Claim
Notice to the Escrow Agent.
(c) Within
20
days after delivery of a Claim Notice, or such shorter period as may be
necessitated by the nature and timing of the suit or proceeding, the
Indemnifying Party shall deliver to the Indemnified Party a written response
(the “Response”) in which the Indemnifying Party shall: (i) agree that the
Indemnified Party is entitled to receive all of the Claimed Amount (in which
case the Response shall be accompanied by a payment by the Indemnifying Party
to
the Indemnified Party of the Claimed Amount, by check or by wire transfer;
provided that if the Indemnified Party is the Buyer, the Indemnifying Party
and
the Indemnified Party shall deliver to the Escrow Agent, within three days
following the delivery of the Response, a written notice executed by both
parties instructing the Escrow Agent to distribute to the Buyer such number
of
Escrow Shares; (ii) agree that the Indemnified Party is entitled to receive
part, but not all, of the Claimed Amount (the “Agreed Amount”) (in which case
the Response shall be accompanied by a payment by the Indemnifying Party to
the
Indemnified Party of the Agreed Amount, by check or by wire transfer; provided
that if the Indemnified Party is the Buyer, the Indemnifying Party and the
Indemnified Party shall deliver to the Escrow Agent, within three days following
the delivery of the Response, a written notice executed by both parties
instructing the Escrow Agent to distribute to the Buyer such number of Escrow
Shares as have an aggregate Value equal to fifty percent (50%) of the Agreed
Amount) of Escrow Shares or (iii) dispute that the Indemnified Party is
entitled to receive any of the Claimed Amount. If the Indemnifying Party in
the
Response disputes its liability for all or part of the Claimed Amount, the
Indemnifying Party and the Indemnified Party shall follow the procedures set
forth in Section 6.3(d) for the resolution of such dispute (a “Dispute”).
For purposes of this Article VI, the “Value” of any Escrow Shares delivered
in satisfaction of an indemnity claim shall be the closing price per share
of
the Buyer Common Stock on the OTCBB on the Closing Date (subject to equitable
adjustment in the event of any stock split, stock dividend, reverse stock split
or similar event affecting the Buyer Common Stock since the Closing Date),
multiplied by the number of such Escrow Shares.
42
(d) During
the 60-day period following the delivery of a Response that reflects a Dispute,
the Indemnifying Party and the Indemnified Party shall use good faith efforts
to
resolve the Dispute. If the Dispute is not resolved within such 60-day period,
the Indemnifying Party and the Indemnified Party shall discuss in good faith
the
submission of the Dispute to a mutually acceptable alternative dispute
resolution procedure (which may be non-binding or binding upon the parties,
as
they agree in advance) (the “ADR Procedure”). In the event the Indemnifying
Party and the Indemnified Party agree upon an ADR Procedure, such parties shall,
in consultation with the chosen dispute resolution service (the “ADR Service”),
promptly agree upon a format and timetable for the ADR Procedure, agree upon
the
rules applicable to the ADR Procedure, and promptly undertake the ADR Procedure.
The provisions of this Section 6.3(d) shall not obligate the Indemnifying
Party and the Indemnified Party to pursue an ADR Procedure or prevent either
such party from pursuing the Dispute in a court of competent jurisdiction;
provided that, if the Indemnifying Party and the Indemnified Party agree to
pursue an ADR Procedure, neither the Indemnifying Party nor the Indemnified
Party may commence litigation or seek other remedies with respect to the Dispute
prior to the completion of such ADR Procedure. Any ADR Procedure undertaken
by
the Indemnifying Party and the Indemnified Party shall be considered a
compromise negotiation for purposes of federal and state rules of evidence,
and
all statements, offers, opinions and disclosures (whether written or oral)
made
in the course of the ADR Procedure by or on behalf of the Indemnifying Party,
the Indemnified Party or the ADR Service shall be treated as confidential and,
where appropriate, as privileged work product. Such statements, offers, opinions
and disclosures shall not be discoverable or admissible for any purposes in
any
litigation or other proceeding relating to the Dispute (provided that this
sentence shall not be construed to exclude from discovery or admission any
matter that is otherwise discoverable or admissible). The fees and expenses
of
any ADR Service used by the Indemnifying Party and the Indemnified Party shall
be shared equally by the Indemnifying Party and the Indemnified Party. If the
Indemnified Party is the Buyer, the Indemnifying Party and the Indemnified
Party
shall deliver to the Escrow Agent, promptly following the resolution of the
Dispute (whether by mutual agreement, pursuant to an ADR Procedure, as a result
of a judicial decision or otherwise), a written notice executed by both parties
instructing the Escrow Agent as to the distribution of Escrow Shares equal
to
the Value of the Claim determined by in accordance with the resolution of the
Dispute (which notice shall be consistent with the terms of the resolution
of
the Dispute).
43
(e) Notwithstanding
the other provisions of this Section 6.3, if a third party asserts (other
than by means of a lawsuit) that an Indemnified Party is liable to such third
party for a monetary or other obligation which may constitute or result in
Damages for which such Indemnified Party may be entitled to indemnification
pursuant to this Article VI, and such Indemnified Party reasonably
determines that it has a valid business reason to fulfill such obligation,
then
(i) such Indemnified Party shall be entitled to satisfy such obligation,
without prior notice to or consent from the Indemnifying Party, (ii) such
Indemnified Party may subsequently make a claim for indemnification in
accordance with the provisions of this Article VI, and (iii) such
Indemnified Party shall be reimbursed, in accordance with the provisions of
this
Article VI, for any such Damages for which it is entitled to
indemnification pursuant to this Article VI (subject to the right of the
Indemnifying Party to dispute the Indemnified Party’s entitlement to
indemnification, or the amount for which it is entitled to indemnification,
under the terms of this Article VI).
6.4 Survival
of Representations and Warranties.
All
representations and warranties contained in this Agreement, the Company
Certificate or the Buyer Certificate shall survive the Closing and any
investigation at any time made by or on behalf of an Indemnified Party and
shall
expire on the date that is thirteen (13) months following the Closing, provided
that those representations and warranties pertaining to Company’s Taxes set
forth in Section 2.9 shall expire on the date that is thirty (30) days following
the third (3rd)
anniversary of the date of Filing of the related Tax Return (or, if applicable,
the date of any voluntary extension to the applicable statute of limitations
that the Surviving Corporation may grant). If an Indemnified Party delivers
to
an Indemnifying Party, before expiration of a representation or warranty, either
a Claim Notice based upon a breach of such representation or warranty, or a
notice that, as a result a legal proceeding instituted by or written claim
made
by a third party, the Indemnified Party reasonably expects to incur Damages
as a
result of a breach of such representation or warranty (an “Expected Claim
Notice”), then such representation or warranty shall survive until, but only for
purposes of, the resolution of the matter covered by such notice. If the legal
proceeding or written claim with respect to which an Expected Claim Notice
has
been given is definitively withdrawn or resolved in favor of the Indemnified
Party, the Indemnified Party shall promptly so notify the Indemnifying Party;
and if the Indemnified Party has delivered a copy of the Expected Claim Notice
to the Escrow Agent and Escrow Shares have been retained in escrow after the
Termination Date (as defined in the Escrow Agreement) with respect to such
Expected Claim Notice, the Indemnifying Party and the Indemnified Party shall
promptly deliver to the Escrow Agent a written notice executed by both parties
instructing the Escrow Agent to distribute such retained Escrow Shares to the
Indemnifying Stockholders in accordance with the terms of the Escrow
Agreement.
6.5 Limitations.
(a) Notwithstanding
anything to the contrary herein but subject to Sections 6.5(c) and 6.5(d),
(i) the aggregate liability of the Indemnifying Stockholders for Damages
under this Article VI shall not exceed the amount of the Escrow Fund, and
(ii) the Indemnifying Stockholders shall not be liable under this
Article VI unless and until (x) any individual Damage incurred by Buyer
exceeds exceed $10,000 and (y) the aggregate Damages incurred by Buyer exceeds
the sum of $250,000 (the “Stockholder Deductible Amount”), at which point the
Indemnifying Stockholders shall become liable for the aggregate Damages equal
to
the Stockholder Deductible Amount plus the Damages in excess of the Stockholder
Deductible Amount;
44
(b) Notwithstanding
anything to the contrary herein but subject to Section 6.5(c), (i) the
aggregate liability of the Buyer for Damages under this Article VI shall
not exceed $2,500,000, and (ii) Buyer shall not be liable under this
Article VI unless and until (x) any individual Damage incurred by the
Indemnifying Stockholders exceeds exceed $10,000 and (y) the aggregate Damages
incurred by the Indemnifying Stockholders exceeds the sum of $250,000 (the
“Buyer Deductible Amount”), at which point the Buyer shall become liable for the
aggregate Damages equal to the Buyer Deductible Amount plus the Damages in
excess of the Buyer Deductible Amount;
(c) The
limitations set forth in clauses (a)(ii) and (b)(ii) above shall not apply
to
(A) a claim pursuant to Section 6.1(a) relating to a breach of the
representations and warranties set forth in Sections 2.1, 2.2, 2.3, 2.13,
2.18 or 2.23 (or the portion of the Company Certificate relating thereto) or
to
a breach of the covenants set forth in Section 4.7, (B) a claim
pursuant to Section 6.2 relating to a breach of the representations and
warranties set forth in Sections 3.1, 3.2, or 3.3 (or the portion of the
Buyer Certificate relating thereto) or (C) a claim with respect to Excess
Transaction Expenses. For purposes solely of this Article VI, all
representations and warranties of the Company in Article II and all
representations and warranties of the Buyer and the Transitory Subsidiary in
Article III shall be construed as if the term “material” and any reference to
“Company Material Adverse Effect” and “Buyer Material Adverse Effect” (and
variations thereof) were omitted from such representations and
warranties.
(d) The
Indemnifying Stockholders shall have no liability for Damages arising from
or
based upon the facts alleged in the Record Label Litigation.
(e) The
Escrow Fund shall be the exclusive means for the Buyer to collect any Damages
for which it is entitled to indemnification under this Article VI. Any
Damages that are satisfied out of the Escrow Fund shall be satisfied by the
delivery of the Escrow Shares to Buyer in accordance with this Article VI and
the Escrow Agreement.
(f) Except
with respect to claims based on fraud, after the Closing, the rights of the
Indemnified Parties under this Article VI and the Escrow Agreement shall be
the exclusive remedy of the Indemnified Parties with respect to claims resulting
from or relating to any misrepresentation, breach of warranty or failure to
perform any covenant or agreement contained in this Agreement.
(g) No
Indemnifying Stockholder shall have any right of contribution against the
Company or the Surviving Corporation with respect to any breach by the Company
of any of its representations, warranties, covenants or agreements.
45
(h) The
amount of Damages recoverable by an Indemnified Party under this Article VI
with
respect to an indemnity claim shall be reduced by (i) any proceeds received
by
such Indemnified Party or an Affiliate, with respect to the Damages to which
such indemnity claim relates, from an insurance carrier, and each Indemnified
Party shall be required to submit all matters underlying an indemnity claim
to
all applicable insurance carriers prior to making a claim pursuant to this
Article VI and (ii) the amount of any tax savings actually realized by such
Indemnified Party or an Affiliate which are attributable to the Damages to
which
such indemnity claim relates (net of any increased tax liability which may
result from the receipt of the indemnity payment or any insurance proceeds
relating to such Damages.
6.6 Indemnification
Representative.
(a) Upon
the
adoption of this Agreement and the approval of the Merger and the transactions
contemplated hereby by the Indemnifying Stockholders, and without further act
of
any Indemnifying Stockholder, Xxxx Xxxxx shall be appointed as the
Indemnification Representative hereunder to give and receive notices and
communications, to authorize payment to Buyer in any case where the Buyer is
the
Indemnified Party from the Escrow Fund in satisfaction of Damages in any case
where the Buyer is the Indemnified Party, to object to such payments, to agree
to, negotiate, enter into settlements and compromises of, and demand arbitration
and comply with orders of courts and awards of arbitrators with respect to
such
Damages, to receive payments on behalf of the Indemnifying Stockholders due
and
owing pursuant to this Agreement and acknowledge receipt thereof, to waive
any
breach or default of Buyer or Transitory Subsidiary under this Agreement
following the Effective Time, to receive service of process on behalf of the
Indemnifying Stockholders and in connection with any claims under this Agreement
or any related document or instrument, and to take all other actions that are
either (i) necessary or appropriate in the judgment of the Indemnification
Representative for the accomplishment of the foregoing or (ii) specifically
mandated by the terms of this Agreement. Such agency may be changed by the
Indemnifying Stockholders from time to time upon not less than thirty (30)
days
prior written notice to Buyer; provided,
however,
that
the Indemnification Representative may not be removed unless holders of a
two-thirds interest of the Escrow Fund agree to such removal and to the identity
of the substituted agent. A vacancy in the position of Indemnification
Representative may be filled by the holders of a majority in interest of the
Escrow Fund. No bond shall be required of the Indemnification Representative,
and the Indemnification Representative shall not receive any compensation for
its services. Notices or communications to or from the Indemnification
Representative shall constitute notice to or from the Indemnifying
Stockholders.
(b) The
Indemnification Representative shall not be liable for any act done or omitted
without gross negligence and or bad faith hereunder as Indemnification
Representative. Pursuant to the following sentence, and to the fullest extent
permitted by applicable Law, the Indemnifying Stockholders shall be, severally
based on such Indemnifying Stockholder’s pro rata share of the Merger
Consideration and not jointly, obligated to indemnify the Indemnification
Representative and hold the Indemnification Representative harmless against
any
loss, liability or expense incurred without gross negligence or bad faith on
the
part of the Indemnification Representative and arising out of or in connection
with the acceptance or administration of the Indemnification Representative's
duties hereunder, including the reasonable fees and expenses of any legal
counsel retained by the Indemnification Representative. At the time of
distribution to
the
Company Stockholders
of
any
proceeds remaining in the Escrow Fund, the Indemnification Representative shall
be entitled to deduct and withhold from the portion of the Escrow Fund included
in such distribution to pay and reimburse fees and expenses of third parties
incurred or expected to be incurred in connection with its role as
Indemnification Representative pursuant to this Agreement to the extent that
the
Indemnification Representative Reserve would be insufficient to pay
and
reimburse fees and expenses of third parties.
46
(c) The
grant
of authority provided for in this Section 6.6:
(i) is coupled with an interest and is being granted, in part, as an
inducement to Buyer and Transitory Subsidiary to enter into this Agreement
and
the Escrow Agreement, and shall be irrevocable and survive the death,
incompetency, bankruptcy or liquidation of the Company or any Indemnifying
Stockholder and shall be binding on any successor thereto and (ii) shall
survive the delivery of an assignment by any Indemnifying Stockholder of the
whole or any fraction of his, her or its interest in the Escrow
Fund.
(d) In
connection with the performance of its obligations hereunder and under the
Escrow Agreement, the Indemnification Representative shall have the right at
any
time and from time to time to select and engage, at the cost and expense of
the
Indemnifying Stockholders, attorneys, accountants, investment bankers, advisors,
consultants and clerical personnel and obtain such other professional and expert
assistance, and maintain such records, as the Indemnification Representative
may
deem necessary or desirable and incur other out-of-pocket expenses related
to
performing its services hereunder.
(e) In
dealing with this Agreement, the Escrow Agreement and any instruments,
agreements or documents relating thereto, and in exercising or failing to
exercise all or any of the powers conferred upon the Indemnification
Representative hereunder or thereunder, (i) the Indemnification
Representative and its agents, counsel, accountants and other representatives
shall not assume any, and shall incur no, responsibility whatsoever (in each
case, to the extent permitted by applicable law) to the Indemnifying
Stockholders, Buyer or the Surviving Corporation by reason of any error in
judgment or other act or omission performed or omitted hereunder or in
connection with this Agreement, the Escrow Agreement or any such other
agreement, instrument or document other than with respect to willful misconduct
or gross negligence on the part of the Indemnification Representative, and
(ii) the Indemnification Representative shall be entitled to rely in good
faith on the advice of counsel, public accountants or other independent experts
experienced in the matter at issue, and any error in judgment or other act
or
omission of the Indemnification Representative pursuant to such advice shall
in
no event subject the Indemnification Representative to liability to the
Indemnifying Stockholders, Buyer or the Surviving Corporation.
(f) All
of
the immunities and powers granted to the Indemnification Representative under
this Agreement shall survive the Closing and/or any termination of this
Agreement and the Escrow Agreement.
(g) A
decision, act, consent or instruction of the Indemnification Representative,
including an extension or waiver of this Agreement, shall constitute a decision
of the Indemnifying Stockholders and shall be final, binding and conclusive
upon
the Indemnifying Stockholders; and the Escrow Agent, Buyer and the Surviving
Corporation may rely upon any such decision, act, consent or instruction of
the
Indemnification Representative as being the decision, act, consent or
instruction of the Indemnifying Stockholders. The Escrow Agent, Buyer and the
Surviving Corporation are hereby relieved from any Liability to any Person
for
any acts done by them in accordance with such decision, act, consent or
instruction of the Indemnification Representative.
47
(h) The
Indemnification Representative has all requisite power, authority and legal
capacity to execute and deliver this Agreement and each other agreement,
document, or instrument or certificate contemplated by this Agreement or to
be
executed by the Indemnification Representative in connection with
the consummation of the transactions contemplated by this Agreement
(together with this Agreement, the “Indemnification Representative Documents”),
and to consummate the transactions contemplated hereby and thereby. The
execution and delivery of this Agreement and each of the Indemnification
Representative Documents, the performance of its respective obligations
hereunder and thereunder and the consummation of the transactions contemplated
hereby and thereby have been duly authorized by all required action on the
part
of the Indemnification Representative. This Agreement has been, and each of
the
Indemnification Representative Documents will be at or prior to the Closing,
duly and validly executed and delivered by the Indemnification Representative
and (assuming the due authorization, execution and delivery by the other parties
hereto and thereto) this Agreement constitutes, and each of the Indemnification
Representative Documents when so executed and delivered will constitute, legal,
valid and binding obligations of the Indemnification Representative enforceable
against it in accordance with their respective terms, subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar laws affecting
creditors’ rights and remedies generally, and subject, as to enforceability, to
general principles of equity, including principles of commercial reasonableness,
good faith and fair dealing (regardless of whether enforcement is sought in
a
proceeding at law or in equity).
(i) For
purposes of Section 6.3 and the last two sentences of Section 6.4,
(i) if the Indemnifying Stockholders comprise the Indemnifying Party, any
references to the Indemnifying Party (except provisions relating to an
obligation to make or a right to receive any payments provided for in
Section 6.3 or Section 6.4) shall be deemed to refer to the
Indemnification Representative and (ii) if the Indemnifying Stockholders
comprise the Indemnified Party, any references to the Indemnified Party (except
provisions relating to an obligation to make or a right to receive any payments
provided for in Section 6.3 or Section 6.4) shall be deemed to refer
to the Indemnification Representative.
ARTICLE
VII
TERMINATION
7.1 Termination
of Agreement.
The
Parties may terminate this Agreement prior to the Effective Time (whether before
or after Requisite Stockholder Approval), as provided below:
(a) the
Buyer
and the Company may terminate this Agreement by mutual written
consent;
48
(b) the
Buyer
may terminate this Agreement by giving written notice to the Company in the
event the Company is in breach of any representation, warranty or covenant
contained in this Agreement, and such breach, individually or in
combination with any other such breach, (i) would cause the conditions set
forth in clauses (c) or (d) of Section 5.2 not to be satisfied and (ii) is
not cured within 20 days following delivery by the Buyer to the Company of
written notice of such breach;
(c) the
Company may terminate this Agreement by giving written notice to the Buyer
in
the event the Buyer or the Transitory Subsidiary is in breach of any
representation, warranty or covenant contained in this Agreement, and such
breach, individually or in combination with any other such breach,
(i) would cause the conditions set forth in clauses (c) or (d) of
Section 5.3 not to be satisfied and (ii) is not cured within 20 days
following delivery by the Company to the Buyer of written notice of such
breach;
(d) the
Buyer
or the Company may terminate this Agreement by giving written notice to the
other Parties at any time after the Company Stockholders have voted on whether
to approve this Agreement and the Merger in the event this Agreement and the
Merger failed to receive the Requisite Stockholder Approval;
(e) the
Buyer
may terminate this Agreement by giving written notice to the Company
pursuant
to Section 4.1 or if
the
Closing shall not have occurred on or before April 29,
2007
(the “Termination Date”) by reason of the failure of any condition precedent
under Section 5.1 or 5.2 hereof (unless the failure results primarily from
a breach by the Buyer or the Transitory Subsidiary of any representation,
warranty or covenant contained in this Agreement);
(f) the
Company may terminate this Agreement by giving written notice to the Buyer
and
the Transitory Subsidiary if the Closing shall not have occurred on or before
the Termination Date unless there exists on the Termination Date a failure
by
the Company to satisfy a condition set forth in Section 5.2;
or
(g) the
Buyer
or the Company may terminate this Agreement by giving written notice to the
other Parties in the event that the Board of Directors of the Company agrees
to
accept a Superior Offer.
7.2 Effect
of Termination.
If any
Party terminates this Agreement pursuant to Section 7.1,
other
than a termination by the Company pursuant to Section 7.1(c) or 7.1(f) or a
termination by Company or the Buyer pursuant to Section 7.1(g), all obligations
of the Parties hereunder shall terminate without any liability of any Party
to
any other Party (except for any liability of any Party for willful breaches
of
this Agreement). Notwithstanding the foregoing, the obligations of the Parties
pursuant to Section 4.5(c) shall survive termination of this Agreement. In
the event of a termination on or before the Termination Date by the Company
or
pursuant to Section 7.1(g) then, the Company shall pay the Buyer the greater
of
(x) $5,000,000 or (y) 25% of the amounts payable to the Company or its
stockholders pursuant to such Superior Offer. In either case of (x) or (y),
the
amount held in escrow pursuant to Section 1.9(d)
shall be
released to the Buyer upon the termination of this Agreement and the additional
amounts payable shall be paid to the Buyer upon the closing pursuant to the
Superior Offer. In the event of a termination by the Company pursuant to Section
7.1(c) or 7.1(f) then, the Buyer shall immediately pay the Company $1,500,000
in
cash. Each Party acknowledges that the agreements contained in this Section
7.2
are an integral part of the transactions contemplated by this Agreement and
constitute liquidated damages and not a penalty, and that, without these
agreements, the other Parties would not enter into this Agreement.
49
ARTICLE
VIII
DEFINITIONS
For
purposes of this Agreement, each of the following defined terms is defined
in
the Section of this Agreement indicated below.
Defined
Term
|
Section
|
|
ADR
Procedure
|
6.3(d)
|
|
ADR
Service
|
6.3(d)
|
|
Affiliate
|
2.14(a)(vii)
|
|
Affiliated
Group
|
2.9(a)(iii)
|
|
Affiliated
Period
|
2.9(a)(iv)
|
|
Agreed
Amount
|
6.3(c)
|
|
Average
Pre-Signing Price
|
1.5(a)(ii)
|
|
Basic
Common Conversion Ratio
|
1.5(a)(ii)
|
|
Basic
Shares
|
1.5(a)(ii)
|
|
Buyer
|
Introduction
|
|
Buyer
Benefit Plan
|
4.11
|
|
Buyer
Certificate
|
5.3(f)
|
|
Buyer
Common Stock
|
1.5(a)(ii)
|
|
Buyer
Deductible Amount
|
6.5(b)
|
|
Buyer
Deliverables
|
3.12(a)
|
|
Buyer
Intellectual Property
|
3.12(a)
|
|
Buyer
Material Adverse Effect
|
3.1
|
|
Buyer
SEC Filings
|
3.5(a)
|
|
Buyer
Software
|
3.12(e)
|
|
CERCLA
|
2.22(a)
|
|
Certificates
|
1.7
|
|
Certificate
of Merger
|
1.1
|
|
Claim
Notice
|
6.3(b)
|
|
Claimed
Amount
|
6.3(b)
|
|
Closing
|
1.2
|
|
Closing
Date
|
1.2
|
|
Code
|
Introduction
|
|
Common
Shares
|
1.5(a)(ii)
|
|
Company
|
Introduction
|
|
Company
Certificate
|
5.2(f)
|
|
Company
Intellectual Property
|
2.13(a)
|
|
Company
Material Adverse Effect
|
2.1
|
50
Company
Shares
|
1.5(a)(i)
|
|
Company
Stockholder
|
1.3(d)
|
|
Confidential
Information
|
4.5(c)
|
|
Continuing
Employees
|
4.11
|
|
Controlling
Party
|
6.3(a)
|
|
Customer
Deliverables
|
2.13(a)
|
|
Customer
Provided Content
|
2.13(f)
|
|
Damages
|
6.1
|
|
Disclosure
Schedule
|
Article II
|
|
Disclosure
Statement
|
4.3(a)
|
|
Dispute
|
6.3(c)
|
|
Dissenting
Shares
|
1.6(a)
|
|
Effective
Time
|
1.1
|
|
Employee
Benefit Plan
|
2.21(a)(i)
|
|
Environmental
Law
|
2.22(a)
|
|
Equitable
Exceptions
|
2.3
|
|
ERISA
|
2.21(a)(ii)
|
|
ERISA
Affiliate
|
2.21(a)(iii)
|
|
Escrow
Agreement
|
1.3(f)
|
|
Escrow
Agent
|
1.3(f)
|
|
Escrow
Fund
|
1.3(f)
|
|
Escrow
Shares
|
1.5(a)(iv)
|
|
Excess
Transaction Expenses
|
4.7
|
|
Exchange
Act
|
2.14(a)(vii)
|
|
Expected
Claim Notice
|
6.4
|
|
Financial
Statements
|
2.6
|
|
GAAP
|
2.8
|
|
Governmental
Entity
|
2.4
|
|
Indemnification
Representative
|
Introduction
|
|
Indemnification
Representative Documents
|
6.6(h)
|
|
Indemnified
Party
|
6.3(a)
|
|
Indemnifying
Party
|
6.3(a)
|
|
Indemnifying
Stockholders
|
6.1
|
|
Intellectual
Property
|
2.13(a)
|
|
Internal
Systems
|
2.13(a)
|
|
IRS
|
2.9(c)
|
|
Legal
Proceeding
|
2.18
|
|
Lockup
Agreement
|
1.8(a)
|
|
M&A
Beneficiary
|
4.11
|
|
Major
Record Label
|
4.4(1)
|
|
Major
Stockholder
|
Introduction
|
|
Managing
Shareholder
|
1.51.5(a)1.5(a)(iii)
|
|
Materials
of Environmental Concern
|
2.22(b)
|
|
Merger
|
1.1
|
|
Merger
Consideration
|
1.5
|
51
Merger
Shares
|
1.5(a)(vi)
|
|
Money
Laundering Laws
|
2.29
|
|
Most
Recent Balance Sheet
|
2.8
|
|
Most
Recent Balance Sheet Date
|
2.6
|
|
Non-controlling
Party
|
6.3(a)
|
|
Non-Managing
Shareholders
|
1.51.5(a)1.5(a)(iii)
|
|
Options
|
1.8(a)
|
|
Option
Plan
|
1.8(a)
|
|
Ordinary
Course of Business
|
2.4
|
|
OTCBB
|
1.5(a)(ii)
|
|
Parties
|
Introduction
|
|
Permits
|
2.25
|
|
Preferred
Shares
|
1.5(a)(i)
|
|
Reasonable
Best Efforts
|
4.1(a)
|
|
Record
Label Litigation
|
2.18
|
|
Response
|
6.3(c)
|
|
Requisite
Stockholder Approval
|
2.3
|
|
SEC
|
3.5(a)
|
|
Securities
Act
|
1.8(d)
|
|
Security
Interest
|
2.4
|
|
Software
|
2.13(e)
|
|
Stockholder
Deductible Amount
|
6.5(a)
|
|
Stockholders
Support Agreement
|
Introduction
|
|
Subsequent
Shares
|
1.5(a)(vi)
|
|
Subsidiary
|
2.5(a)
|
|
Superior
Offer
|
4.3(b)(i)
|
|
Surviving
Corporation
|
1.1
|
|
Taxes
|
2.9(a)(i)
|
|
Tax
Returns
|
2.9(a)(ii)
|
|
Termination
Date
|
7.1(e)
|
|
Transaction
Expenses
|
4.7
|
|
Transaction
Expenses List
|
4.7
|
|
Transitory
Subsidiary
|
Introduction
|
|
Value
|
6.3(c)
|
|
Warrants
|
1.8(e)
|
|
Zeocast
Litigation
|
2.18
|
ARTICLE
IX
MISCELLANEOUS
9.1 Press
Releases and Announcements.
No
Party shall issue any press release or public announcement relating to the
subject matter of this Agreement without the prior written approval of the
other
Parties; provided,
however,
that
any Party may make any public disclosure it believes in good faith is required
by applicable law, regulation or stock market rule (in which case the disclosing
Party shall use reasonable efforts to advise the other Parties and provide
them
with a copy of the proposed disclosure prior to making the
disclosure).
52
9.2 No
Third Party Beneficiaries.
This
Agreement shall not confer any rights or remedies upon any person other than
the
Parties and their respective successors and permitted assigns; provided,
however,
that
(a) the provisions in Article I concerning issuance of the Merger
Shares and Article VI concerning indemnification are intended for the
benefit of the Company Stockholders and (b) the provisions in
Section 4.8 concerning indemnification are intended for the benefit of the
individuals specified therein and their successors and assigns.
9.3 Entire
Agreement.
This
Agreement (including the documents referred to herein) constitutes the entire
agreement among the Parties and supersedes any prior understandings, agreements
or representations by or among the Parties, written or oral, with respect to
the
subject matter hereof; provided that the Confidentiality Agreement dated
December 1, 2006 between the Buyer and the Company shall remain in effect in
accordance with its terms.
9.4 Succession
and Assignment.
This
Agreement shall be binding upon and inure to the benefit of the Parties named
herein and their respective successors and permitted assigns. No Party may
assign either this Agreement or any of its rights, interests or obligations
hereunder without the prior written approval of the other Parties; provided
that
the Transitory Subsidiary may assign its rights, interests and obligations
hereunder to an Affiliate of the Buyer.
9.5 Counterparts
and Facsimile Signature.
This
Agreement may be executed in two or more counterparts, each of which shall
be
deemed an original but all of which together shall constitute one and the same
instrument. This Agreement may be executed by facsimile signature.
9.6 Headings.
The
section headings contained in this Agreement are inserted for convenience only
and shall not affect in any way the meaning or interpretation of this
Agreement.
9.7 Notices.
All
notices, requests, demands, claims, and other communications hereunder shall
be
in writing. Any notice, request, demand, claim or other communication hereunder
shall be deemed duly delivered four business days after it is sent by registered
or certified mail, return receipt requested, postage prepaid, or one business
day after it is sent for next business day delivery via a reputable nationwide
overnight courier service, in each case to the intended recipient as set forth
below:
If
to the Buyer, or the Transitory Subsidiary:
GoFish
Corporation
000
Xxxxx Xxxxxx Xxxxx 000
Xxx
Xxxxxxxxx, XX 00000
Attn:
Xxxxxxx Xxxxxxx, President and Chief Executive Officer
Facsimile:
(000) 000-0000
|
Copy
to (which copy shall not constitute notice
hereunder):
McGuireWoods
LLP
0000
Xxxxxx xx xxx Xxxxxxxx
Xxx
Xxxx, XX 00000
Attn:
Xxxxx X. Xxxxx, Esq.
Facsimile:
(000) 000-0000
|
If
to the Company:
Bolt
Media, Inc.
000
Xxxxxx Xxxxxx, 0xx Xxxxx
Xxx
Xxxx XX 00000-0000
|
Copy
to (which copy shall not constitute notice
hereunder):
Xxxxx
Xxxxx Xxxx Xxxxxx
Xxxxxxx
and Xxxxx, P.C.
000
Xxxxxxxxxxxx Xxxxxx, X.X.
Xxxxx
000
Xxxxxxxxxx,
X.X. 00000
Attn:
Xxx X. Xxxxxx, Esq.
Facsimile:
(000) 000-0000
|
53
If
to Indemnification Representative:
Xxxx
Xxxxx
0000
Xxxxxxxx Xxxx
Xxxxxx,
XX 00000
|
Any
Party
may give any notice, request, demand, claim or other communication hereunder
using any other means (including personal delivery, expedited courier, messenger
service, telecopy, telex, ordinary mail or electronic mail), but no such notice,
request, demand, claim or other communication shall be deemed to have been
duly
given unless and until it actually is received by the party for whom it is
intended. Any Party may change the address to which notices, requests, demands,
claims, and other communications hereunder are to be delivered by giving the
other Parties notice in the manner herein set forth.
9.8 Governing
Law.
This
Agreement shall be governed by and construed in accordance with the internal
laws of the State of Delaware without giving effect to any choice or conflict
of
law provision or rule (whether of the State of Delaware or any other
jurisdiction) that would cause the application of laws of any jurisdictions
other than those of the State of Delaware.
9.9 Amendments
and Waivers.
The
Parties may mutually amend any provision of this Agreement at any time prior
to
the Effective Time; provided,
however,
that
any amendment effected subsequent to the Requisite Stockholder Approval shall
be
subject to any restrictions contained in the Delaware General Corporation Law.
No amendment of any provision of this Agreement shall be valid unless the same
shall be in writing and signed by all of the Parties. No waiver of any right
or
remedy hereunder shall be valid unless the same shall be in writing and signed
by the Party giving such waiver. No waiver by any Party with respect to any
default, misrepresentation or breach of warranty or covenant hereunder shall
be
deemed to extend to any prior or subsequent default, misrepresentation or breach
of warranty or covenant hereunder or affect in any way any rights arising by
virtue of any prior or subsequent such occurrence.
9.10 Severability.
Any
term or provision of this Agreement that is invalid or unenforceable in any
situation in any jurisdiction shall not affect the validity or enforceability
of
the remaining terms and provisions hereof or the validity or enforceability
of
the offending term or provision in any other situation or in any other
jurisdiction. If the final judgment of a court of competent jurisdiction
declares that any term or provision hereof is invalid or unenforceable, the
Parties agree that the court making the determination of invalidity or
unenforceability shall have the power to limit the term or provision, to delete
specific words or phrases, or to replace any invalid or unenforceable term
or
provision with a term or provision that is valid and enforceable and that comes
closest to expressing the intention of the invalid or unenforceable term or
provision, and this Agreement shall be enforceable as so modified.
54
9.11 Submission
to Jurisdiction.
Each of
the Parties (a) submits to the jurisdiction of any state or federal court
sitting in San Francisco, California in any action or proceeding arising out
of
or relating to this Agreement, (b) agrees that all claims in respect of
such action or proceeding may be heard and determined in any such court, and
(c) agrees not to bring any action or proceeding arising out of or relating
to this Agreement in any other court. Each of the Parties waives any defense
of
inconvenient forum to the maintenance of any action or proceeding so brought
and
waives any bond, surety or other security that might be required of any other
Party with respect thereto. Any Party may make service on another Party by
sending or delivering a copy of the process to the Party to be served at the
address and in the manner provided for the giving of notices in
Section 9.7. Nothing in this Section 9.11, however, shall affect the
right of any Party to serve legal process in any other manner permitted by
law.
9.12 Construction.
(a) The
language used in this Agreement shall be deemed to be the language chosen by
the
Parties to express their mutual intent, and no rule of strict construction
shall
be applied against any Party.
(b) Any
reference to any federal, state, local or foreign statute or law shall be deemed
also to refer to all rules and regulations promulgated thereunder, unless the
context requires otherwise.
[Signature
Page Follows]
55
IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first
above written.
GOFISH CORPORATION
|
||
|
|
|
By: |
/s/ Xxxxxxx Xxxxxxx
|
|
Title: Chief Executive Officer |
||
BM ACQUISITION CORP INC. | ||
|
|
|
By: | /s/ Xxxxxxx Xxxxxxx | |
Title: Chief Executive Officer |
||
BOLT, INC. | ||
|
|
|
By: | /s/ Xxxxx Xxxxx | |
Title: Chief Executive Officer |
||
INDEMNIFICATION REPRESENTATIVE | ||
|
|
|
By: | /s/ Xxxx Xxxxx | |
Xxxx Xxxxx |
||